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FOREWORD 
Recent advances in the treatment of typhoid fever and 
erysipelas have been made the subjects of this thesis. In 
the first section, an evaluation of the serum treatment of 
enteric fever with the new serum devised by Felix is presented, 
and the significance of the results obtained is discussed in 
detail. In the second part, an analysis of the treatment of 
a large series of cases of erysipelas with the recently 
introduced drugs belonging to the sulphanilamide group is given. 
Both studies, it is believed, enable certain conclusions to be 
drawn which are of very great practical importance. 
PART I. 
THE SPECIFIC TREAT1TENT OF TYPHOID FEVER. 
PART I - THE SPECIFIC TREATMENT OF TYPHOID FEVER. 
INTRODUCTION 
The history of the treatment of typhoid fever by the 
aduinistration of a specific serum dates back to the beginning 
of this century. 
Since then various sera have been employed by different 
workers, and although encouraging, and even at times brilliant 
results have been claimed for many of them by individual 
observers, these successes have never been generally substantiated. 
The prevailing opinion as to the value of such sera is, for 
instance expressed thus: "There is no convincing generally 
acceptable proof of the efficacy of any specific serum, so far 
used, in spite of many favourable reports the results are 
frankly too uncertain, and any good effects on the course of the 
disease are possibly due to a foreign protein action "(1) Other 
authorities are substantially in agreement. 
That none of the antityphoid sera have found general approval 
appears to be due mainly to the following factors: they have not 
been widely available for use in different countries and in 
different outbreaks; their comparatively restricted use has not 
been accurately controlled; furthermore even if they had been 
available there is probably a certain reluctance on the part 
of most to employ a remedy the rationale of which is uncertain, 
unless the proof of its efficacy is overwhelming. For there 
has been and still is a lack of precise knowledge of the specific 
antibacterial elements which take part in attacking the typhoid 
bacillus in the body, and of the antigen- antibody mechanisms 
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involved in the building up of immunity. 
Thus Gay(2) has remarked that "there is little ultimate 
opinion on the question of the nature of the poisons present or 
excreted by the typhoid bacillus, than which no subject is more 
involved in a mass of experimental data" and Ker(3) that "the 
chief difficulty in preparing a typhoid antitoxin is the fact 
that the toxin of the bacillus typhosus is an endotoxin, and 
its isolation therefore is hard to obtain ". 
It is true that certain investigators, e.g. Chantemesse(4) 
and Gross(5) claim to have grown a soluble exotoxin from the 
typhoid bacillus and to have prepared a specific antitoxin from 
it. Nevertheless authoritative opinion is almost unanimous 
that the typhoid bacillus forms no true exotoxin. Topley 
and Wilson(6) sum up current views on the subject thus: "We 
know little of the way in which the typhoid bacillus gives rise 
to the toxaemia there has been no evidence of neutralisation 
in multiple proportions which is so characteristic of diphtheria 
or of tetanus antitoxin How far the toxic symptoms 
are due to endotoxins, and how far they are the result of bacterial 
anaphylaxis is not known. In particular we do not know whether 
the iiiuiiunity which follows an attack of typhoid is wholly anti- 
bacterial, or whether there is an antitoxic element which has 
escaped our analysis ". 
It is hardly surprising therefore that the serum treatment 
of typhoid should be so full of uncertainties, and so beset 
with problems. 
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PATHOGENESIS of TYPHOID FEVER in LAN. . 
The typhoid bacillus usually enters the body via the 
alimentary tract. After gaining access to the upper part of 
the small intestine the organisms do not multiply to any extent 
here but pass at once through the wall of the intestine especially 
at the lymph follicles and Peyers' Patches to the intestinal 
lymphatics and thence to the mesenteric lymph nodes and spleen. 
This phase probably corresponds to the incubation period and :ay 
be associated with vague symptoms of general malaise. The 
organisms are then carried in the lymph stream to the thoracic 
duct and so into the bloodstream. 
In the bloodstream many organisms are at once destroyed 
and their toxins set free or elaborated, thus causing the fever, 
lethargy, headache, and other symptoms of the disease. Others 
are carried by the bloodstream all over the system - and especially 
to the liver, spleen, gall bladder, and bone -marrow. The 
blood changes characteristic of typhoid viz., the leucopenia and 
the disappearance of polymorphs and eosinophils are due to their 
proliferation in the last named situation. 
From the liver the bacilli pass along the liver lymphatics 
and bile canaliculi to the gall- bladder where they multiply 
freely in the bile and are carried thence to the intestines, 
and they are usually at this stage, particularly in the second and 
third week of the disease, to be recovered in large numbers from 
the faeces. In the intestine they cause characteristic 
inflammation, necrosis and ulceration of the Peyers' Patches and 
lymph nodes, especially of the ileum, which are fraught with 
the dangerous possibilities of haemorrhage and perforation. 
Later the bacilli are carried in the blood to the kidney 
and multiply in the pelvis of the kidney and in the urinary 
bladder. 
Typhoid fever is thus essentially an infection of the 
lymphatic system in which the special brunt falls on the lymph 
follicles of the small intestine and the mesenteric lymph nodes. 
The bacteraemia is a secondary phenomenon, in virtue of which 
the toxaemia, and the manifold complications of the disease are 
due - such as pleurisy, pneumonia, laryngitis, nephritis, arthritis, 
meningitis. 
The gall -bladder plays a prominent part in the pathogenesis 
of the disease, for it acts as a reservoir and breeding- ground 
for the organisms, is sometimes the seat of an actual typhoid 
cholecystitis, and is largely responsible, even after recovery 
has set in, for the persistent carrier state. 
It will thus be evident that the possible pathological 
lesions in any given case are manifold and difficult to 
prognosticate. Cases in which nephritis (nephrotyphoid) or 
pneumonia (pneumotyphoid) or meningeal symptoms (meningotyphoid) 
dominate the clinical picture sometimes occur. Again the 
disease may run its course almost entirely as a toxaemia, the 
intestinal lesions being slight or absent. On the other hand 
the patient may have little or no toxaemia and yet deep ulceration 
of the bowel may be present. 
Furthermore the immunological phenomena are at times baffling. 
Although the routine laboratory diagnostic methods give practically 
100% certainty, there seems to be little correlation between the 
degree of agglutination of the blood -serum of an infected individual 
and the degree of immunity. Nor can the agglutination titre 
in any given case be used as a prognostic guide. It is also 
known that even in the presence of a high agglutination titre a 
relapse may occur, and that after recovery from the disease the 
agglutinins may apparently disappear, and yet the individual be 
immune. 
Again profound toxaemia and the most severe ulceration may 
occur in the course of typhoid, and yet both serological tests 
and examination of the excreta may be entirely negative, though 
this is no doubt rare. 
The pathological and innumological manifestations of 
typhoid are thus complex to a degree. Thus factors of non- 
specific immunity, of general resistance or lack of resistance, 
and of local iinnunity probably play a more incalculable part 
in typhoid than in any other acute fever, and may be calculated 
to frequently upset any attempted direct antidotal attack on 
the disease. 
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HISTORY of the RESEARCH on the PREPARATION 
of the NEW ANTI -SERUM. 
An appreciable advance in the clarification of the whole 
subject of the antigenic structure of B.typhosus was fore -shadowed 
by Smith and Reagh(7) in their discovery of the fact of antigenic 
variation while working with the hog- cholera bacillus, and their 
demonstration of the flagellar and somatic types of agglutination. 
Their work was amply corroborated and extended by Weil and Felix( 
8) 
who in the case of B.proteus described the two forms of antigen: 
the thermo- labile flagellar antigen (H) and the thermo- stable 
somatic antigen (0); and further by Arkwright(9) who investigated 
particularly the cola- typhoid -dysentery group of bacteria and 
discovered the Smooth - Rough variation to which these organisms 
were prone. It was soon thereafter established that the 
smooth form was usually associated with virulence, and the rough 
form with avirulence. Finally White(10) and Kaufl ann 
11' 
making use of agglutination and agglutinin -absorption methods, 
,lade a minute analysis of the antigenic structure of the typhoid - 
group of organisms. 
As a result of these investigations a picture of the antigenic 
structure, so far as it is known of the typhoid bacillus emerges, 
which is now universally accepted as a working basis in the field 
of bacteriological practice. For the sake of simplicity, and 
in view of a further antigenic constituent which has recently been 
discovered by Felix and his co- workers, and which has a bearing 
on the subject of this thesis, this picture of the typhoid bacillus 
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may be briefly described as follows: - 
The normal form of the typhoid bacillus gives a smooth 
growth on agar and is flagellated and_ virulent. It is referred 
to as the Smooth (S) Form. The flagellar antigens are 
thermolabile and are not concerned in the virulence of the 
organism. They are antigenic in that they stimulate the 
formation of specific agglutinins, but they probably take no 
part in the production of effective imunity. 
The virulence of the smooth form of the typhoid bacillus 
resides in the somatic antigen which is heat- stable. For 
convenience the somatic antigen is usually regarded as residing 
at the surface of the bacterial cell, for it is in this situation 
that reactions take place rendering the cell susceptible to 
phagocytosis and to lysis by complement. The somatic antigen 
is also type- specific in respect of agglutination. 
Under certain cultural conditions the smooth form becomes 
rough: this is associated with a loss of the somatic antigen, of 
virulence, and of specificity, and with the "unmasking" of the 
"group" antigen and the formation of rough colonies on agar. 
The transition from smooth to rough may not always be clear -cut. 
These changes in the antigenic form of the two types of 
antigen, H and 0, may take place independently of each other. 
The significant point is that it is the 0 antigen and the 
corresponding 0 antibody which are so far concerned in the question 
of ii1Llunity in typhoid. How far, if indeed at all, such 
antigen- antibody reactions can be exploited in the treatment of 
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typhoid is still problematical. 
Interest in the serum treatment of typhoid has recently been 
renewed by Felix and his co- workers. In pursuing their 
investiations further, they came to the conclusion that the 
mere presence of 0 antigen does not in itself determine high 
virulence, but that some unknown character is required to render 
this antigen resistant to the action of the 0 antibody.(12) 
Later they showed, as the result of iniunization experiments 
on mice that this unknown character was itself an antigen, and 
that the corresponding antibody was a powerful protecting agent. 
They applied the names "Vi antigen" and "Vi antibody" respectively 
to them. The interesting point about this Vi antibody is 
that it was effective in protecting mice even after complete 
removal of the 0 antibody. On the other hand the latter 
neutralizes the endotoxin of the T.typhosus, an action of which 
the Vi antibody is incapable.(13) 
Finally it was found that whereas in agglutination and 
protection experiments the Vi and 0 antiiodies acted independently 
of each other, in phagocytosis experiments there was a suul_iation 
effect between the two, although the Vi antibody was the superior 
( 11+ ) 
in its power of promoting phagocytosis of virulent typhoid bacilli. 
In view of the above findings the assumption was justifiably 
made that a serum containing a sufficient quantity of the Vi and 
the 0 antibodies might be helpful in the treatment of human typhoid 
fever. Such a serum has been prepared by the Lister Institute, 
and it is a clinical trial with this serum that forms the subject 
of the first part of this thesis. 
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PREVIOUS CLINICAL TRIALS with the NEW LISTER IFSTITUTE SERUM. 
At the present time the results in four series of cases of 
typhoid fever treated with the Lister Institute Serum have been 
published. 
(15) 
(1) Felix (1935) reported forty -three cases, together with 
seventeen controls who received normal horse serum. The 
antityphoid serum used was unconcentrated and had maximum 
agglutination titres for Vi and 0 antibodies of 1.00 and 40,000 
respectively. 
Of the forty -three cases favourable effects were noted on 
the toxaemia in twenty -four and on the temperature in twenty- 
three. Twelve cases were classed as extremely severe and of 
these five died (a total case ;mortality of 11.L ). The usual 
dose of serum was 50 ccs given intramuscularly but in severe cases 
this was repeated twice, and in extremely severe cases it was 
given intravenously. 
It is to be noted here that although the clinicians in charge 
of the cases were convinced of the efficacy of the serum, the 
controls are unsatisfactory, since they constitute less than half 
in number of the serum- treated cases, and the case mortality is 
not mentioned. 
(2) McSweeney (1935)(16) recorded the results in eight patients 
treated in Dublin, one of whom died, and later (1936) at a meeting 
of the Fever Group of the Society of Medical Officers of Health 
reported nineteen cases in all (including the eight above mentioned) 
treated with the serum in whom there were three deaths. There 
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was only one complication viz., a suppurative cervical adenitis 
and in the twelve of eighteen cases who showed varying degrees of 
toxaemia all toxaemic symptoms had "vanished" within 48 hours. 
LicSweeney was not only favourably impressed but even enthusiastic 
in regard to the serum. 
Here again it must be observed that the series is inadequately 
controlled. Furthermore a study of the temperature charts 
published in connection with his earlier cases suggests that they 
were not really severe cases on the whole - in only one case, and 
that on one occasion only does the temperature reach 103 °F. 
(3) Robertson and Yu (1936)(17) report a series of fifty -six 
patients treated in China, four of whom received the Lister 
Institute Serum, and the remaining fifty -two an almost identical 
serum. Of the fifty -six patients treated, thirty -two showed 
definite, many of them dramatic, improvement indicated by a drop 
in temperature and a reduction of toxaemia, and only sixteen 
cases showed no appreciable benefit from the serum. 
The remaining eight cases showed a reduction of toxaemia but 
no change in the temperature curve. 
A closer analysis of this series is interesting, for it shows 
that out of twenty -four extremely or very ill patients, seven 
were greatly or dramatically improved, two showed a lessening of 
toxaemia and one was improved temporarily but died suddenly. 
The improvement rate here then, in the really severe cases, 
was at the most about 40% and in view of the fact that many of 
these patients were treated with the serum in the third week or 
later when one might reasonably begin to look for improvement 
in any case, it is impossible to say how much may merely have been 
incidental. 
A series of controls here would also have been interesting. 
However it is noteworthy that the authors were very favourably 
impressed with the efficacy of the serum, and state specifically 
that they were "careful and unbiassed observers." 
(4) The fourth and largest series of cases is that of 
Harold Cookson and R. V. Facey(18) in connection with the 
Bournemouth epidemic of 1936 when seventy -eight cases were 
subjected to the serum treatment. Of these 73% showed improvement 
within 48 hours of injection of the serum, and a further 10% a few 
days later. The case mortality was 9.5%. 
Most of the cases treated were severe or very severe, and 
were treated relatively late in the disease, and although the 
report is lacking in detail, and no figures are given for the 
non -serum treated patients, there seems little doubt that the 
serum was of some value. 
Looking at the four series as a whole amounting as they do 
to close on two hundred cases, and allowing for inadequate control 
of the cases and insufficient recording etc., one may reasonably 
reach the following conclusions: 
(1) In a high percentage the serum causes a reduction in toxaemia, 
sometimes remarkable, within a few days of being administered. 
This effect however is not so definite or so constant in the very 
severe cases. 
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(2) A reduction in temperature is also effected in a high 
percentage of cases. 
(3) In many cases the disease is apparently cut short. 
(4) The fatality -rate in the entire gfoup is 10.7%. No 
evidence is adduced to indicate that this figure is lower than it 
would have been had no serum been administered. 
On the basis of the above it will be seen that the acid test 
of the efficacy of any treatment, viz., a reduction in the 
mortality rate, is discretely avoided. 
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PRESENT INVESTIGATION. 
The following account gives a description of the results 
that have been obtained by treating nineteen patients with a 
concentrated antityphoid serum containing the "Vi" and "0" 
antibodies as described by Felix, and prepared by immunizing 
horses at the Lister Institute. The agglutinin titres of 
the antibodies in the serum were 
1/600 for the Vi and 1/60,000 for the 0 antibody. 
The ideal clinical trial would have consisted in dividing 
the patients into four groups (reasonably comparable as to age and 
sex distribution, the stage of the disease at the commencement 
of treatment, and the severity of the attack) viz., 
Group I. - Those treated with Felix's serum containing 
both Vi and 0 antibodies. 
Group II. - Those treated with a serum containing 0 
antibodies alone. 
Group III. - Those treated with normal horse serum. 
Group IV. - Those treated in a purely symptomatic way. 
Unfortunately this was not possible owing to paucity of 
numbers (39 cases in all). It was therefore decided to form 
two groups, viz., I. and IV, the latter acting as a control group. 
Nineteen (19) cases were treated by serum (Group A.) and the 
remaining twenty (20) cases without serum (Group B.) 
All occurred in the same epidemic, and with eight exceptions 
they all belonged to the primary outbreak. All had the same 
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nursing staff and the same medical attention and case -recording, 
and the other factors referred to above, will be seen on reference 
to be fairly uniform. Apart from the adiainistration of the 
serum no discrimination whatever was made between the two groups. 
All the cases referred to were bacteriologically proved 
cases of typhoid as shown in the following table:- 
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SUL1-.IARY of the BACTERIOLOGICAL FINDINGS in this SERIES. 





Urine H 0 Faeces 
1 + 1:50 - - - 
2 + 1:100 1:50 + - 
3 + - 1:25 + - 
4 + 1:4.00 - + - 
5 + - 1:100 - - 
6 + 1:25 - - - 
7 + 1:200 - + - 
8 + 1:25,000 1:200 - - 
9 + 1:800 1:800 + - 
10 + 1:1600 1:200 + - 
11 + - _ _ _ 
12 - 1:25 1:50 - - 
13 + 1:50 - + + 
14 + 1:100 - - - 
15 + 1:400 1:400 + - 
1 6 + 1:25,000 1:400 + - 
17 - 1:25 -- + - 
18 + - 1:200 + - 
19 + 1:200 1:200 - - 
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1 + - 1:200 + - 
2 + - 1:100 + - 
3 - 1:50 - + - 
4 + 1:400 - - - 
5 - 1:400 1:100 + + 
6 + 1:25,000 1:50 + + 
7 + - 1:200 + - 
8 + 1:50 - + - 
9 + 1:12,500 1:400 + - 
10 + 1:12,000 1:500 + - 
11 + 1:400 - + - 
12 - 1:25,000 1:400 + - 
13 + 1:25 1:50 + - 
14 + 1:200 1:200 + + 
15 + 1:800 1:200 + - 
16 + 1:400 1:400 + - 
17 + 1:50 1:1600 + - 
18 - 1:50 1:50 + - 
19 - - - + - 
20 - 1:1600 1:50 + - 
-17- 
In assessing the severity of the disease in each case the 
following factors mainly were taken into account: The 
general appearance and decubitus of the patient, the presence or 
absence of cyanosis, the rate and character of the pulse, and 
the character of the heart sounds, the presence or absence of 
diarrhoea and of ineteorism, the degree of nervous prostration as 
evidenced by apathy, delirium, incontinence, etc., and the 
degree and character of the pyrexia. 
In order to afford as strict a control series as possible 
the alternate case method was adopted, with one exception: 
this was a patient originally in the serum -group who during the 
administration of the serum had a violent anaphylactic reaction 
after the injection of a few drops. The serum was therefore 
abandoned in her case and as the small amount which she had was 
not considered to finally influence her condition she was regarded 
as a control case. 
It is believed that the account of the treatment of patients 
with this particular antityphoid serum is the first described 
in this country which has been strictly controlled by the 
alternate case method. 
Dosage of the Serum. 
The serum was diluted with an equal quantity of normal 
saline, and was given slowly by the intravenous method, except 
in two cases where it was given intramuscularly. 
In the absence of any criterion as to severity of infection 
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or lack of resistance that is at once reliable and easily 
applied an empirical dose was decided on, following mainly the 
manufacturer's recomu:endations, of 25 c.c.s. for three doses 
on successive days; occasionally the dose was doubled or repeated 
at longer intervals, and in the case of children it was reduced 
in amount. The actual dosage is given on the chart of each 
treated individual. 
Where special sensitivity to serum was suspected, the 
patient was tested for this before proceeding with the therapeutic 
dose, having been first desensitized if necessary. In all 
cases 5 minims of 1:1000 adrenalin was injected before administering 
the serum as an additional precaution against untoward reactions. 
In almost all cases some reaction was noted within a few 
minutes from the beginning of the injection, that is when 5 - 10 ccs 
had entered the vein. This consisted in an increased pulse - 
and respiratory - rate, lasting as a rule for a few minutes, and 
sometimes rather distressing to the patient. In most cases 
from one to three hours later, there was a rigor with or without 
an initial rise of temperature, the temperature falling again in 
the course of an hour or two. In three cases the reaction was 
attended by considerable collapse and in one of these to be 
described later there was a fatal issue. In three cases there 
was an immediate anaphylactic reaction of an alarming character. 
In one of them as mentioned the treatment was abandoned, in a 
second it was continued by the intramuscular route, and in the 
third by the intravenous route. 
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In the majority of cases serum sickness in the form of a 
more or less generalised urticarial rash developed at times 
varying from 1 - 17 days after the last dose of serum - in 
one case within a few hours of the first dose of serum. This 
was followed in a certain number of cases by generalised joint 
pains with sometimes some swelling of the joints. In one 
case a peripheral neuritis with tingling, numbness and weakness 
of the left upper extremity appeared apparently in relation to 
the serum rash. A median nerve palsy which developed during 
convalescence in one patient was regarded as being due to a toxic 
neuritis rather than a serum phenomenon, but the latter explanation 
is a possibility. 
The temperature charts of all the cases, serum and control, 
until defervescence supervened or until the end of the fourth 
week where the fever was prolonged beyond this time, are now 
reproduced; likewise the pulse rates, the times of administration 
of the serum and the outstanding incidents in the course of the 
disease together with a clinical summary of each case. 
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SERUM TREATED CASES. 






ilMm nrmrfaLl4c«7+fY7r/as][Pf idr: íiir i b ' ' 1? MMMIMMO®®  . 
I 






Case 1. A.':'d. male 55. 
Admitted during incubation period. Gradual rise of 
temperature which reached 103.2°F. on 5th day of illness. 
Administration of serum as shown. Collapse about 2 hours 
after serum, with clammy skin, prostration, feeble pulse, and 
subnormal temperature. There was no indication at this stage 
that the patient was seriously ill. Apart from the temporary 
fall in temperature after the first dose, the serum had no 
evident effect for good and the patient became progressively 
worse. Though 55 years of age he was a robust man. He 
ran the whole gamut almost of the common complications except 
perforation, including several intestinal haemorrhages, 
cholecystitis, pneumonia and pleurisy with effusion, and bilateral 
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thrombophlebitis of the lower extremities, and he died finally 
on the 61st day of his illness in the most pitiable state of 
emaciation and exhaustion. In addition to his specific therapy, 
this man had three blood transfusions with, however, only temporary 
benefit. Culture of the fluid from his chest gave a pure 
growth of B.typhosus. 
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Case II. B.M. female 34. 
Moderately severe in the early stages when serum was given. 
The pyrexia possibly was modified by serum - the general condition, 
toxaemia, abdominal distension, and delirium were unaffected. 
The temperature became normal on 21st day, followed at once by a 
recrudescence with the development of a lobar pneumonia, meteorism, 
repeated intestinal haemorrhages, a severe it tocarditis and death 
on the 41st day of the disease in status typhosus. The patient 
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had two blood transfusions without appreciable benefit. 
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Case III. W. P. (Senr.) male 53. 
Patient not markedly toxic on admission but became gradually 
worse. Severe rigor after the first dose of serum followed by 
collapse. The temperature rose again and continued to swing. 
Patient "does not feel so well" the following day - complexion 
grey, pulse markedly dicrotic, tympanites increasing, profound 
prostration. Toxaemic symptoms and meteorism became progressively 
worse and the patient died in status typhosus on 2th day of the 
disease. A generalised dusky erythematous rash appeared on 
the day before death - probably due to seruì,.. 
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Case IV. i,.. C. female 69. 
An old hemiplegic - a pneumo- typhoid in whom admittedly 
the prognosis was bad from the outset. She was given two 
doses of serum intramuscularly. Patient bordering on status 
typhosus; had inelaena on 14th and 1th day of the disease and 
died the following day. Serum probably had little effect 
one way or the other. 
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Case V. P. T. male 14. 
Very severe case. The temperature fell by crisis after 
the first dose but rose again. Patient noted as feeling and 
looking better the following day. A second dose was given 
two days later with a similar effect. On both occasions a 
severe rigor followed the administration of the serum. The 
day following the second dose, the patient was not so well, and 
had a further rigor. His rose spots became extremely profuse, 
and he took on the typical typhoid appearance with delirium (day 
and night), a dry brown tongue, enlarged spleen, tumid abdomen 
and diarrhoea with "peasoup" stools. After a third dose of 
serum on the 10th day of the disease the temperature certainly 
fell to a lower level but there was no improvement in the general 
condition of the patient. His temperature came down to normal 
on the 25th day of the disease, but this was followed three days 
-25- 
later by a relapse with recurrence of all the symptoms. Serum 
was again persevered with, with no apparent improvement whatsoever. 
This boy developed spasticity with ankle -clonus, and a +ve Babinski 
of the left lower extremity, which was presumably myelitic in 
origin. His temperature eventually became normal on the 50th day 
of the disease and he remained in hospital for 14 weeks on account 
of his debility. 
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Case VI. J. P. male 21. 
The patient was severely ill with grave toxaemia, cyanosis, 
"tick- tack" heart sounds, and a markedly dicrotic pulse. He 
had a violent reaction with rigor following the administration 
of the first dose of serum, and the subsequent doses were given 
intramuscularly. The serum had no effect whatever so far as 
one could judge on either temperature, toxaemia, or subsequent 
-26- 
course of the disease. He had a relapse on the 40th day of 
the disease, the temperature finally reaching normal on the 
54th day. During the sixth week he developed "tender toes ". 
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Case VII. V. R. female 28. 
Patient admitted within 24 hours of first feeling ill. 
She was given one dose of 25 c.c.s of serum intravenously. About 
an hour later she collapsed with all the appearances of a severe 
case of surgical shock. She was cold and clsmrì;y with a 
subnormal temperature, a feeble running pulse, tick -tack heart 
sounds, and had repeated retching. Adrenalin was given 
intravenously followed by morphia and atropin hypodermically, 
subcutaneous salines and intravenous gum saline. Pituitrin 
and adrenalin were continued 4 hourly. The patient never 
rallied but gradually became unconscious and died about 30 hours 
-27- 
later. 
Post morteu exaiiination was not granted, but there was not 
the slightest suspicion of haemorrhage or perforation here, and 
it is almost certain that death was directly due to serum shock. 
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Case VIII. W.T. male 15. 
A moderately severe case which did very well. 
temperature was probably modified by serum, 
impression was gained that the toxaemia was 
The 
and the clinical 
also moderated by 
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Case IX. G. I. male 16. 
Fairly severe case. Teuperature fell after first dose 
of serwn, following a severe rigor about two hours after injection, 
but rose again. General condition and toxaemia not apparently 
influenced. Peasoup stools continued, and remarkably profuse 
crops of rose spots appeared during the next few days. 
Defervescence set in on the twenty -sixth day of disease. Con - 
:valescence prolonged on account of general exhaustion. Patient 
became extremely childish and wept frequently for days on end 
without apparent reason. 
J V MALL 
Date 
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Case X. J. B. male, 32. 
A fairly ill patient, with loose stools, incontinence of 
urine and noisy delirium. This man was probably on the mend 
when serum therapy was instituted as judged from his pulse and 
temperature chart, though he still looked toxic. On the day 
following his first dose of seruu he was noted to be "looking better" 
but after the second to be "looking worse ". He continued to be 
incontinent of urine for several days subsequently though this was 
probably due mainly to perverseness. His temperature eventually 
became normal on the 31st day, and his convalescence was slow. 
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Case XI. W. P. (Junr.) male 28. 
Moderately ill patient. Serum commenced on the third 
day of the disease. He had a serum reaction during and 
immediately after each injection consisting of pain in the hands 
and feet and severe abdominal cramp, pallor and throbbing in the 
head, but no change in pulse or respiration. This was followed 
by shivering. The course of the disease was apparently 
unaltered by the treatment. He developed melaena for three 
days at the end of the second week. The temperature became 
normal on the twenty -third day of the disease. 
. I i.l.re T. 
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Case XII. T. B. male 33. 
Serum given late, but disease still active. Fresh rose 
spots appeared on the 21st day of illness, when edge of spleen 
also became palpable. This was probably a recrudescence of 
the disease. Serum given the following day and on alternate 
days for two subsequent doses. Very violent serum reaction with 
rigor followed by collapse, and giving rise to serious anxiety. 
Subsequently the pyrexia was possibly modified but there was no 
improvement in the patient's well -being - indeed the contrary. 
Six days after the last dose of serum he was noted to be 
"tremulous, haggard, anxious and feeble." Cardiac condition 
poor. He developed a median nerve palsy which lasted for 
several weeks, with anaesthesia over the index, middle and radial 
-32- 
half of the ring fingers of the right hand, weakness of the grip 
of the right hand and wasting of the first dorsal interosseous 
muscle. The pyrexia subsided on the 31st day of the disease. 
Convalescence very slow. 
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Case XIII. Mrs McL. female 58. 
Moderately ill. Serum treatment commenced on the 6th 
day of the illness. A rigor followed the first and second 
injections. There was a temporary subsidence of the pyrexia 
after each injection. The subsequent temperature curve and 
toxaemia remained so far as one could judge quite unaffected. 
On the twenty -third day she developed melaena and diarrnoea 
which lasted for several days. She finally became apyrexial 
on the 38th day of the illness apart from slight elevations on 
-33- 
and off until the 54th day. 
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Case XIV. D. F. male 10. 
_ ceros uir,c4c CHAR,) 
The temperature fell by crisis after the 
doses of the serum, but rose again. 
first and third 
There was no noticeable 
abatement of the toxaemia and the course of the fever continued 
much as one might expect. 
A relapse with enlargement of the spleen, fresh rose spots 
and abdominal distension took place on the 31st day of the 





4Zr.1RL6._.__..Age 35 . . Diseuse _yPllo/A 
, , 
771f._/.ti`7771 l8! /q io Z!! 
FEVER y«,D-__ R 




M E M E M EdM EM E M E M E 
I5- 
98' 
/LLM/SJ CLINICAL CRART/ 
Case XV. H. McL. female 35. 
The temperature was probably modified by the serum in this 
case, and the toxaemia possibly favourably influenced. Two 
days after the third dose of serum, however, her rose spots were 
still very bright, and she was noted to have a "peasoup" stool. 
Vomiting was troublesome during the second week of the disease. 
After 50 c.c.s of serum on the thirteenth day of her illness 
there was a distinct improvement in the patient's general condition 
although she had a troublesome serum sickness with urticaria and 
athralgia followed later by numbness and loss of power in the 
hands. Defervescence set in on the twentieth day and she had 
no complications apart from the above mentioned. 
Convalescence was slow. 
-35- 
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Case XVI. Lirs T. female, 36. 
A mild case who had serum on the tenth and eleventh days 
of her illness following which her temperature fell by lysis to 
normal. Noted as feeling better on the fifteenth day. 
Convalescence uneventful. The spleen remained palpably 
enlarged till the thirty- fourth day of the disease, though her 
temperature became normal on the twentieth day. 
The impression was got that this case probably benefited 
by the treatment. 
-36- 
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Case XVII. Mrs J. S. female 20. 
A mild case who had serum on the seventh, ninth, and tenth 
days. She developed Scarlet Fever on the eighth day of her 
illness, and this was treated by antiscarlatinal serum. 
The typhoid aborted on the twelfth day of her illness 
and her subsequent progress was uneventful. 
Case possibly benefited by serum. 
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Case XVIII. Lirs I. female 47 
The serum had no obvious effect on this patient but she 
did quite well. The pyrexia ceased on the 47th day, being 
maintained evidently by bronchitis. (She had a frequent 
history of bronchitic attacks and had well marked emphysema). 
No other complications, b'.it she became a persistent faecal 
carrier - cured by cholecystectomy. 
. v,.N. 
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Case XIX. J. S. female 3. 
A mild case with very little evidence of toxaemia. 
Became apyrexial on the sixteenth day and had an uncomplicated 
convalescence. 
-39- 
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Case I. J. C. male 23. 
Admitted on fifth day of illness. Always looked very 
toxic and prostrated. Developed a markedly dicrotic pulse. 
Coryza and bronchitis supervened a week after admission; Koplik's 
spots were noted and a brilliant discrete measles rash appeared 
two days later. Two days after this he had an intestinal 
haemorrhage which was repeated several times in the course of 
the next few days. He had a blood transfusion on the eighteenth 
day but did not show any appreciable improvement. He sank 
into the status typhosus with low muttering delirium, incontinence 
and a failing circulation, and died on the twentieth day of the 
illness. 
It seems probable that in this man an attack of measles in 
the second week of a severe attack of typhoid turned the scales 
against him and was at least partly responsible for precipitating 
his death. 
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Case II. B. M. female 19. 
Admitted on the fifth day of her illness, and became 
desperately ill during the next fortnight shen she presented the 
classical picture of a severe typhoid, with double incontinence, 
a dry brown cracked tongue, frequent peasoup stools, meteorism 
and status typhosus. Her illness was complicated by a 
troublesome furunculosis and by a B. Coli cystitis. Convalescence 
was prolonged, but eventually she made a good recovery. 
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Case III. Mrs M. female 28. 
Not particularly ill to begin with, but developed a relapse 
which was much more serious than the primary attack. She was 
originally in the serum group, but after having about lc.c. of 
serum she had a most alarming anaphylactic reaction with intense 
air -hunger, cyanosis, a feeble pulse, vomiting and collapse. 
These tymptoms were relieved by intravenous adrenalin. There 
was no history here of a previous injection of serum, or of 
allergy, and she was evidently an "atopic" individual. 
Her primary attack subsided in about a fortnight but was 
followed at once by a severe relapse in the course of which she 
had "peasoup stools ", repeated intestinal haemorrhages and much 
442- 
prostration and delirium. 
Her convalescence was slow but uneventful except for the 
most bitter complaint of "tender toes ". 
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Case IV. J. Y. female 5. 
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Case V. W. B. male 32. 
Admitted at the end of the primary attack and a few days 
later developed a relapse with the classical symptoms and signs - 
rose spots, enlarged and tender spleen, abdominal tumidity, a 
dry brown cracked tongue, and peasoup stools. 
This subsided on the forty -third day from the commencement 
of the illness. Convalescence was protracted but uneventful. 
/MRS- /1. fCA' 7NLE Age 56 Liaeasc I:y.PXOIb EFR 3L dr 
ozzmu N 
O // IL /3 / / 
M V ; w C N c14 W E M E M E M E 














, ® ESHMÜMMMM ! 
ME= 
éC:iTi'óY ° : --- uumum mummEm Ilr71iT.+f1/ry/snslVi.mm Er IIZ4t 1 IlS7[ F7I /47/l/fRi ar..=0ñ=m C dQi 





Case VI. Mrs R. female 56. 
A constitutionally delicate woman with a moderately severe 
attack of typhoid. Her cardiac condition gave cause for 
some anxiety, her heart showing evidence of failure with 
hypostatic congestion and oedema of the ankles. Her fever 
subsided on the twenty -third day of her illness, but she had 
an attack of cholecystitis ten days later, followed by a 
troublesome cystitis. 
This patient became a persistent faecal and urinary 
carrier. The gall -bladder was later successfully removed, 
but she remained a urinary carrier. 
-45- 
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Case VII. Bella L.cG. female, 16. 
Patient sent to another institution on account of 
haematemesis and fever, and admitted here on the twelfth 
day of her illness. She had had splenectomy performed 
eighteen months previously on account of splenic anaemia. She 
was pale and anaemic but not markedly toxic, and apart from 
repeated uelaena which may have been attributable to the splenic 
anaemia, she made an excellent recovery. 
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Case VIII. L.rs E. female 21. 
A moderately ill patient, whose fever ran an uncomplicated 
course with subsidence on the twenty -first day of her illness. 
,.x., W M`L. MALE 
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Case IX. W. Lac. male 28. 
A fairly severe case admitted on the sixth day of illness. 
Dicrotism and low pressure pronounced. Electrocardiographic 
tracing showed evidence of a toxic myocarditis. Tympanites 
marked. He eventually made an excellent recovery. The 
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Case X. R. S. female 72. 
-36° 
Admitted on the seventh day of her illness. Diagnosed 
by her f a...ily physician as pneumonia. Very little temperature 
reaction to the infection, but well marked toxaemia with a 
dry brown cracked tongue, a tumid abdomen, loose stools and 
considerable prostration. The temperature became normal 
on the thirteenth day. Convalescence was slow hut uneventful. 
. 1 it sm.. .1 M. MaLE 
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Case XI. J. L. male 21. 
Classical typhoid of moderate severity which ran an 
uncomplicated course. The temperature became normal on 






MAC. E D I,.0,1 TyPHOiQ. FEvg R . Bendt. B 
1/Jhv 
. 
/O i3 21 2 21 -¡ 1.30 31 3Z // I /L /ú //li /%:/ f 14 l0 








M [ M I M E M rM EIM E11 ( M E.M CM E ME( ril pLAjIME Y. E 
3e=Si 














r. ' . 





















. -. . 
e 
- 
7 : - 1 , -7-1- it g .g Gó EUNE _ - 1 t. r 
rts_ia6sì.alsi 
. . . . _ 
' H!I1àiIIHHI _ 






_- 1p Y Z_ . p 41.: /r,t.,91-4 .10 .7l_ . o. '  ton do 8B 
MÓ 
- - - - - -- 





Case XII. A. T. male 10. 
Admitted on the tenth day - height of the fever passed. 
Patient pale, apathetic and toxic. Had a relapse on the 
twenty- fourth day which lasted about a week. Uneventful 
recovery. 
-51- 
to 2i 22 23 .paIfeirsarsal 
/3_ 
()./.7I1I I RETIE IAC7lClì[lA r7ir7iC7iIlA,r./7.1.K71577 Ell /.7[laW 
. 17Mnr*1r73 i11 czie^1r77/ rnr7irnas73r7Wfami71 iRrR W RiRR1R irW WarRtrRrti i/111=1111/EMNIMfrril WWW 
MUM ®® tiAif® R® 
E». . t. . .eAR 
Case XIII. J. male 28. 
Admitted on the eleventh day of illness - moderately ill. 
His symptoms were mainly pulmonary. He was mentally confused 
for several days and had delusions, but otherwise his progress 
was uneventful and the fever subsided on the thirtieth day. 
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Case XIV. Kits I cG. female 1+9. 
A moderately severe case who had delirium, tympanites, 
and double incontinence without actually exhibiting "the 
typhoid state ". On the eighth day after admission she 
developed a hypostatic pneumonia at the left base which 
resolved satisfactorily. At the same stage she had melaena 
stools for several days, and after the temperature had fallen 
to normal on the twenty -third day she had a relapse which lasted 
two and a half weeks. 
She subsequently made an excellent, though slow, recovery. 
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Case XV. J. S. male 29. 
A mild case who had been admitted to another hospital 
in the first instance as a case of pneui,lonia. This case 
had a leucocytosis of 15,000 cells, while the blood culture 
at the same time gave a profuse growth of B.typhosus. 
Recovery was rapid and uneventful. 
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Case XVI. E. D. female 8. 
The patient was originally sent to a general hospital as 
a case of "acute abdomen ". The abdomen was tender and tumid 
on admission here. The disease aborted on the sixteenth 
day, the only feature of note being a generalised norbilliform 
erythema which appeared on the fourteenth day and lasted for 
three days. 
C. /)c-K . 
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Case XVII. C. ?.:c. female 26. 
Evidently in the remittent stage on admission to hospital. 
Was tired, listless, deaf, and constipated but not seriously 
ill. No complications. 
MAC., 
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Case XVIII. D. R. male 26. 
Also in the remittent stage on admission to hospital. 
Had had epistaxis, sore throat, and abdominal pain. Practically 
no toxaemia. Became convalescent on the twenty-fourth day. 
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Case XIX. W. h. .hale 27 
An ambulant case admitted here on the seventeenth day 
and already almost convalescent. 
T 41 AcE 
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Case XX. W. T. male 39. 
Also an ambulant case who had been ill for three weeks. 
Practically convalescent on admission to hospital. 
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ANALYSIS of the RESULTS of TREAT..ENT. 
An examination of the various factors which might influence 
the results can now be made. In the first instance, a 
study of the age incidence in the two groups showed the 
following: - 





(Non -Serum Treated) 
Under 5 years 1 0 
5 - 9 years 0 2 
10 - 14 years 2 1 
15 - 19 years 2 2 
20 - 24 years 2 3 (1)+ 
25 - 29 years 
(1)+ 
7 
30 - 34 years 3 (1)+ 1 
35 - 39 years 2 1 
40 - 44 years 3 0 
45 - 49 years 1 1 
Over 50 years 4(3)+ 2 
19 (5)+ 20 (1)+ 
+ Figures in brackets indicate deaths. 
It will thus be seen that considering the small total 
number of cases, the distribution of the patients in the two 
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groups according to age is fairly uniform. Nineteen cases 
were treated with serum as against twenty cases in the control 
group. The average age in the serum- treated group was 
31.8 years as against 28.2 years in the control group. 
The distribution of sex incidence was as follows:- 









This also was a satisfactory feature from the point of 
view of the analysis. 
The stage of the illness at which the various patients 
were admitted to hospital and were treated was next analysed 
with the following result:- 
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(Non -Serum Treated) 


















8th day of Disease. 
Thus in the serum- treated groups twelve cases were 
admitted in the first and six in the second week of their 
illness as compared with nine cases and eight cases respectively 
in the control group. 
Next the cases were classified according to the severity 
of the disease when admitted, with the following result:- 
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Mild or Abortive 
3 (3 died) 
3 (1 died) 
9 (1 died) 
4 




Here the figures suggest that the serum- treated group were, 
on the whole. more severely ill than the control group. 
Summing up the above findings, the conclusion can be made 
that so far as age, sex, and stage of illness on admission, are 
concerned, there was little difference in the two groups, but 
that there was a slight preponderance of more severely ill cases 
in the serum- treated as compared with the control group. 
The effect of serum in the treatment of these cases may 
now be considered. In the first instance, the mortality in 
the serum treated group was 5, while in the control group only 
1 individual succumbed. In the serum treated group, 2 
individuals had been treated in the first week of their illness, 
2 in the second week, and 1 in the third. The percentage 
mortality rate for all cases was 15.45, --of the serum- treated 
group 26.3%, and of the control group 5. 
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Again, the average duration of pyrexia in the serum - 
treated group was 28 days, whilst in the control group it was 
25 days. A composite temperature chart has been prepared 
for the individuals of each group up till the end of 4 weeks 
and is given below. This chart shows no significant difference 
between the course of the pyrexia in either group of cases. 
CHART showing the AVERAGE COURSE of the PYREXIA 
in the SERUYI and the CONTROL GROUPS. 
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An examination of the case sheets as regards the incidence 
of complications and relapse showed the following: - 
















































+ One case (Case VII - Control) probably due to splenic anaemia. 
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Thus here again the course of the disease was found to 
be more favourable in the control than in the serum- treated 
cases. Excluding the case of Scarlet Fever in the serum 
group and the case of Leasles in the control group (which are 
extraneous to the point under review), sixteen complications 
occurred in the serum -treated group as against ten in the 
control group, while four cases in each group developed a 
relapse. 
Finally the average duration of stay in hospital was 
considered. In the sera.i- treated group, where two persistent 
carriers were excluded the patients were retained for a 
period of L.9 days. In the control group, after the elimination 
of one permanent carrier and three temporary ones (over six 
weeks) the average length of period in hospital was 50 days. 
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DISCUSSION. 
The most constant effect of the serum was the thermal 
reaction occurring usually one to three hours after injection, 
and frequently most distressing to the patient. In some 
cases it was accompanied by a good deal of collapse, and in 
one of those there was unfortunately a fatal termination. 
In three of the cases there was an im.:iediate reaction of 
an anaphylactic nature. One of those reactions was so 
alarming that the treatment was abandoned, and the patient 
transferred to the control group; in another the serum was 
subsequently given intramuscularly; and in the third it was 
somewhat heroically continued by the intravenous route. About 
two- thirds of the patients developed serum sickness of varying 
severity characterised by an urticaria' rash, with or without 
pyrexia, in all cases, and in some by joint pains, nausea, and 
in one or two by nervous manifestations. 
In view of the severe nature of the reactions one is bound 
to admit that the intravenous route of administration is 
contraindicated. In severe cases of Diphtheria and perhaps 
Scarlet Fever, intravenous serum is usually regarded as not 
only warranted but strongly indicated. But in a slow fever 
like typhoid it is difficult to see what advantage there is to 
be gained by this route, unless the uncertain and sometimes 
undesirable effect of protein shock. 
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A study of the temperature charts in the serum series 
indicates that the serum apparently has the effect of frequently 
reducing the temperature - but only temporarily; and it is as 
a rule difficult to detect a permanent modification in the 
temperature curve. It is possible, however, that in five of 
the cases viz., Nos. 8, 15, 16, 17, and 19, the pyrexia was 
modified and its total duration cut short. 
No constant or frequent amelioration in the patient's 
condition was observed as a result of serum therapy - indeed it 
is sometimes noted that the patient appeared to be worse after 
the treatment. 
Anything in the nature of a "dramatic improvement" 
following serum administration was conspicuous by its absence. 
A comparison of the serum- treated and the control cases 
in relation to the duration of the disease, the length of 
stay in hospital, the incidence of complications and of relapse 
and the case mortality does not by any means show up the control 
series in a disadvantageous light - On the contrary it is the 
serum- treated cases which suffer by comparison. 
The experimental foundation of the serum is impressive 
and its almost total failure therapeutically is not easy to 
explain. Although it is well known that there is no disease 
of animals which is identical with typhoid, and that typhoid 
cannot be artificially produced in animals(15) it is perhaps 
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not unreasonable to expect as Felix says that the same 
antibacterial mechanisms should be involved in man as in animals. 
There are however a few considerations which arise here: 
Firstly the possibility that the factor of local immunity 
in Besredka's sense may be involved. It is generally 
accepted that whereas in man the central features of the disease 
are the inflammation and ulceration of the Peyers' Patches and 
the solitary lymph follicles of the intestine(19; in experimental 
infection of animals the dominating feature is a toxaemia. 
Whilst it is obvious that human typhoid is also a toxaemia of 
varying severity, its peculiar seriousness resides in the fact 
that complications so frequently occur - especially haemorrhage, 
perforation and pneumonia, not to mention the high incidence of 
relapse. Were one able to eliminate these complications, the 
mortality from typhoid would undoubtedly be considerably reduced. 
In other words it is possible to conceive of the development of 
a satisfactory humoral immunity in the course of the disease - 
an izii..iunity which is frustrated as far as the well -being of the 
patient is concerned by the continued activity of the local intest- 
inal lesions - Here is a factor, then, which scarcely applies 
to experimental typhoid in animals. 
Again, the experimental work of Felix clearly indicates that 
his animals were "protected" before they were infected. Although 
it would of course be impracticable to carry out such experiments 
in human beings, it would be interesting and instructive to attempt 
the serum treatment of already infected animals. For instance 
Pfeiffer found that whereas the serum of immunized goats had a 
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certain protective action on animals against the subsequent 
injection of virulent living typhoid bacilli, this agent was 
practically valueless when applied only after the animals had 
been infected.(20) 
Apart from these general considerations, however, which 
admittedly do not go to the root of the matter in question, 
certain striking anomalies have arisen in relation to the role 
of the Vi antigen and its corresponding antibody in the case of 
typhoid infection. In a recent study of the antigenic fraction 
of the typhoid bacilli isolated from carriers and cases, and 
the antibody content of the serum of these patients, Lois Almon 
and his co- workers(21) have found that although nearly all 
typhoid cases are caused by organisms containing the Vi antigen, 
yet the Vi antibody is found in these individuals only occasionally 
and at irregular, unpredictable times, and bears no relation to 
their swiftness of recovery. They conclude therefore that the 
roles of this antigenic fraction and its corresponding antibody 
in the progress of infection and recovery are very obscure. 
Indeed this conclusion finds some support in the results 
of a previous investigation on the same lines by Felix and his 
colleagues(22) in cases of typhoid occurring in Palestine. Here 
only two out of ninety strains of typhoid bacilli were found to 
be devoid of the Vi antigen and yet out of 100 sera taken from 
typhoid patients only 8 contained Vi antibody. It is true that, 
as the authors state, in the majority the serum was taken before 
the end of the second week, whereas in 12 convalescent sera 5 
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contained the Vi antibody - a rauch higher proportion. But 
one cannot refrain from thinking in view of these findings, that 
whatever the role of the Vi antigen and the Vi antibody in human 
typhoid, they can scarcely be dominating factors in the course 
of the disease. 
Finally Kauffmann(23) goes so far as to say as a result of 
his investigations on the Vi antigen in typhoid infection that 
those strains (of B.typhosus) which contain the largest auounts 
of Vi antigen cannot be distinguished in the slightest by mouse - 
inoculation experiments so far as multiplication, virulence, etc., 
are concerned from strains which do not contain the Vi antigen, 
provided "acute toxic doses" are not injected, and that the Vi 
antigen of the mouse- typhoid bacilli described and Pitt 
does not possess any significance so far as virulence is concerned. 
"There is no proof" he states "that virulence is determined by 
any single antigen in the Salmonella group ". 
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SUI.íMARY AND COIdCLUSIOIdS. 
1. An account is given of the treatment of nineteen 
cases of typhoid fever by a new antityphoid serum. 
2. The serum embodies an antibody (the Vi antibody) 
which protects mice experimentally against virulent 
strains of the typhoid bacillus; and also an 0 antibody 
which theoretically neutralises the endotoxins of the 
germ. 
3. Whilst claims are made by other investigators on 
behalf of the efficacy of the serum in human disease, 
they are unconvincing on account of inadequacy of control. 
4. In the present series of cases the results of 
treatment do not indicate that the serlim is of benefit 
in typhoid. 
5. It is suggested that the complexity of typhoid 
fever as a pathological and clinical entity and the 
uncertainty which exists in regard to the role of the 
various antigenic constituents of the typhoid bacillus 
THE 
in evolution of the disease render the latter peculiarly 
unamenable to any specific serum therapy so far known. 
6. In the present investigation the numbers are too 
small for statistical significance to be attached to them. 
They are sufficient, however, to show that the intravenous 
route of administration of the serum is undesirable. 
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Part II. THE CHEiiOTHERAPY OF ERYSIPELAS. 
INTRODUCTION 
More than two years have elapsed since Domagk(1) announced 
certain remarkable results which he had obtained by the use of 
a newly- synthesised drug (referred to as " Prontosil', in the 
treatment of mice experimentally infected with virulent haemolytic 
streptococci. Since then a very extensive literature has 
appeared relating to the application of the drug and certain 
allied compounds in the treatment of haemolytic streptococcal 
and various other bacterial infections in human beings. Setting 
aside the latter it may be mentioned at once that the prevailing 
commentary of those who have employed prontosil in haemolytic 
streptococcal disease is distinctly favourable. With one or 
two notable exceptions however, the individual accounts, numerous 
as they are, are scanty and unconvincing in themselves, since they 
deal with small numbers or even isolated cases. 
This criticism applies also to the several, chiefly German, 
papers describing the treatment of erysipelas with prontosil. 
Nevertheless Scheurer(2'refers to the effect of the drug as 
"striking ", Wehren(3) as "dramatic ", Kramer (4) regards it as 
(5' as "remarkably effective" whilst 
Anghelesen and his co-workers 
(6) 
and Tonndorf(7' who made very 
"specific", Frankl 
exact investigations, the first in a series of forty cases and 
the second in a series of twenty -two are equally impressed by 
the efficacy of the remedy. Lore recently a carefully 
controlled series of cases in this country has been published 
by Snodgrass and Anderson (8) and a further series by Breen and 
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Taylor(9) Their evidence likewise is clearly in favour of 
the drug. 
Practically all who have had experience in the use of 
prontosil agree that considering its potency it is exceptionally 
well tolerated, non -toxic, and apart from certain exceptions to 
be mentioned later, surprisingly free from undesirable by- effects, 
provided certain precautions are observed. 
The present investigation deals with the treatment by 
prontosil of seventy -seven consecutive cases of erysipelas 
admitted to the City Hospital, Aberdeen during the period June 
1936 to June 1937. It was originally prompted by a study of 
the case -records and charts of the previous four or five hundred 
cases including a personal experience of about 140 cases - that 
is those admitted from April 1934 to June 1936 - the result of 
which suggested that erysipelas ran its own course virtually 
unaffected by any treatment; in particular the disease process 
appeared to be wholly indifferent to the exhibition of antitoxic 
serum which was given in a large r..ajority of cases. Furthermore 
the incidence of complications and relapse appeared to be more or 
less constant, and the death -rate undesirably high even allowing 
for the fact that, in Birkhang's phraseology, "erysipelas as a 
terminal infection aligns itself with bronchopneumonia in being 
the effective agent in causing death in many chronic and incurable 
diseases ". 
Incidentally this review of the case- records did not reveal 
any gross variation in the general type and incidence of the 
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disease from year to year. Hence it was decided, heretical 
though it may be from a strictly scientific angle, to dispense 
with alternate control cases and to utilise for comparison with 
the series under investiation consecutive antecedent cases. 
For this purpose the 462 immediately preceding cases were taken - 
that is six groups of seventy -seven. They cover the period 
from January 1928 to June 1936, and they represent all cases 
diagnosed as erysipelas after admission to hospital during 
that period. 
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THE PATHOGENESIS Or ERYSIPELAS. 
The present conception of erysipelas is that it is an 
acute infectious disease of the skin or more rarely of the raucous 
membranes adjoining the skin, caused by a haemolytic streptococcus 
which gains access through trauma, gross or imperceptible. Its 
comparatively frequent occurrence in the region of the face may 
be attributed partly to the fact that slight trauma from scratching 
etc., is likely to be more common about the nose, eye and lips 
than elsewhere in the body, and partly to the anatomical proximity 
of the face to the throat and nasal cavities. 
Whatever weight one attaches to the seed on the one hand 
and the soil in the other in a consideration of the incidence of 
infectious disease, there can be little doubt that in erysipelas 
the constitutional factor is important. Lar:-e series of cases, 
e.g. Boston and Blackburn's(10) and Ker's(ii) show that the 
disease is relatively uncommon in childhood and indeed up to about 
twenty years of age, that it becomes progressively more com_ron as 
age advances, and that the largest absolute number of cases falls 
within the fifth decade of life, Schultz(12) points out that the 
maximum peak of incidence is reached in the 45 - 50 year period, 
and believes that climacteric factors may be concerned in women 
at any rate. Again erysipelas would appear to have a particular 
predilection for the subject of chronic debilitating disease, for 
the alcoholic, for the person living under poor hygienic conditions, 
and for the obese. 
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Bacteriology - 
All are agreed that the exciting cause of erysipelas is a 
haemolytic streptococcus. There has been rauch controversy 
however as to whether it is a specific erysipelas streptococcus; 
indeed the question is still not absolutely decided, although 
the evidence in favour of non -specificity is strong. Fehleiser 
originally produced erysipelas experimentally in human beings 
by scratching into their skin pure cultures of a streptococcus 
isolated from a case of erysipelas, and he was therefore led to 
regard the organism as specific. Petruschky(14) on the other 
(13) 
hand produced the disease by the inoculation of streptococci from 
the pus in a case of peritonitis, and TilLans(15) produced deep 
suppuration in a man by the inoculation of a pure culture of a 
streptococcus from a case of erysipelas. 
Again classification of the haemolytic streptococci by 
agglutination methods shows that although certain strains of the 
organism may fall into certain serological groups, there is a 
general basic similarity among them whatever disease they are 
taken fro;a(i6), nor can they be differentiated serologically 
according to the particular disease to which they give rise.(17) 
Similarly, in spite of Birkhaug's(18) claim that the 
streptococcus of erysipelas produced a specific exotoxin 
responsible for certain manifestations of the disease, in-..v.no- 
:logically distinct from the erythrogenic toxin of Scarlet _'ever, 
and capable of stimulating the formation of a homologous antitoxin, 
his work appears to lack adequate confirmation. Indeed it 
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would seem to have been conclusively proved by McLachlan(19), 
J. Smith(20) and others that the majority of strains of haemolytic 
streptococci from diverse sources of human disease produce one and 
the saine toxin. 
If the above be true it follows as a natural corollary that 
there is no specific erysipelas antitoxin, and that any virtue 
which may be derived from such a supposed antitoxin will depend 
not on its specific antierysipelas properties (which it does not 
in fact possess) but on the extent to which the common erythrogenic 
toxin of the haemolytic streptococcus figures in the disease. 
Pathology and Clinical Features - 
Histopathologically erysipelas is an acute inflammation 
of the skin or mucous membranes, due to the penetration of the 
haemolytic streptococcus into the lymphatic vessels of the corium. 
In certain cases especially when the disease is located in an 
extremity the subcutaneous tissues are also involved (phlegmonous 
erysipelas) producing a cellulitis, which frequently goes on to 
suppuration. Ordinarily there is a vigorous cellular exudative 
reaction of the skin tissues which manifests itself as a brilliant 
red not, tender erythema sometimes with superficial blistering, 
with a well- defined raised spreading edge, and fading at the 
centre as it spreads peripherally. 
Biopsy sections of the erysipelatous lesion show that the 
lymphatic vessels in the corium and surrounding connective tissue 
are completely filled with chains of streptococci. There is 
a perivascular leucocytic infiltration and an out- pouring of 
lymphocytes and mononuclear cells around the lymphatic vessels. 
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Pyogenic processes, apart from the phlegraonous cases, are usually 
absent. 
The spread of the lesion is variable in extent and duration. 
It tends to be arrested where the skin is tensely stretched as 
in the re,;ion of the upper part of the brow and to spread rapidly 
where the tissues are loose as in the eyelids; it may however 
spread all over the body (Erysipelas migrans). Usually the 
rash lasts about a week but it may exist only for a day or two, 
or for many weeks. 
The inflammatory process usually terminates by crisis, 
the polymorphonuclear leucocytes and lymphocytes disappear 
completely from the affected parts, the epidermis desouamates and 
a brownish staining remains for a few days or longer. 
In certain cases the streptococcus takes on more pyogenic 
and invasive characters, producing septicaemia and various 
complications arising therefrom, such as pyaemic subcutaneous 
abscesses, pneumonia and empyema, pericarditis, suppurative 
nephritis, arthritis, and thrombophlebitis. Sometimes the 
local action of the toxin is apparently peculiarly intense and 
actual necrosis and gangrene of the skin of the inflamed area 
takes place. 
The visceral chan es are those common to any acute tvxaa_iia. 
Febrile albuminuria is common; in a small percentage of cases an 
acute haemorrhagic nephritis is present. 
Leucocytosis and regional lymphadenitis are practically 
constant accompaniments of the disease. 
The temperature is variable in duration, extent, and 
-81- 
character. It may be high and continuous, or remittent, or 
completely irregular. Usually defervescence synchronises with 
subsidence of the inflammatory lesion, and an exacerbation or 
spread of the inflammation calls forth a fresh rise in temperature. 
In a small percentage of cases pyrexia is entirely absent, due 
sometimes it would seem to mildness of the disease, and sometimes 
to debility of the patient. 
Delirium is common in severe cases, especially where the 
scalp is involved, and in alcoholic patients. 
Death when it occurs is due usually to toxaemia, septicaemia, 
pneumonia, carditis, nephritis or alcoholism. 
IL;,XNITY - 
Immunity as the result of an attack of erysipelas if it 
exists at all is short lived, relapses and second attacks 
occurring more frequently here than in any other acute bacterial 
infection. Not even a local immunity can be detected, for 
the inflammation sometimes involves the same area of skin 
repeatedly. The brilliant rosy red of erysipelas strongly 
suggests to one the action of an erythrogenic toxin, and yet 
presuming it is due to the latter, when one compares the conditions 
with those prevailing in Scarlet Fever, it is curious that in the 
case of erysipelas the toxin should be capable of calling forth 
the same skin reaction again and again, but in scarlet fever only 
once in the vast majority of cases. 
Whatever be the reason it would appear that erysipelas is 
unique in its complete failure to activate the immunity mechanism 
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of the body both in an antitoxic and an antibacterial direction. 
Prognosis: - 
In general the prognosis in erysipelas is fairly good. 
Ker's 1 613 consecutive cases(21) show a case mortality of 5.7%, 
Erdman' s 800 22) 11.6%, while Goodall and Washbourne(23) state 
that the fatality rate in London cases is about LF . Age, 
however, has a marked influence on the prognosis. Erysipelas 
is particularly deadly in young infants and in old and weakly 
persons. Alcoholism here, as in pneumonia, is a serious 
complication but not met with very frequently to -day. Concurrent 
and incurable diseases likewise affect the prognosis for the 
worse, and any estimation of the fatality rate must take account 
if possible of the influence of these diseases. 
The anatomical situation(21) of the lesion has also a 
bearing on the outcome. Then the disease affects the face 
the outlook is better than when an extremity is involved. 
Cases where the trunk is involved, other things beins- equal, are 
the most serious of all. 
Complicated cases as those originating in surgical trauma, 
and phleaonous cases, are more serious than the simple 
"idiopathic" cases. 
Treatment:- 
It is probable that for reasons already put forward no 
specific treatment has hitherto been available for erysipelas. 
Nevertheless Birkhaug's antitoxic serum prepared against the 
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exotoxin of haemolytic streptococcal strains derived from cases 
of erysipelas has been extensively used. There is no 
convincing evidence of its consistent efficacy, and any benefit 
which it may confer in individual instances is probably accidental. 
For all intents and purposes the same remarks are apposite in 
the case of scarlatinal antitoxin which has also been widely 
used in erysipelas. ì::ultivalent anti- bacterial streptococcal 
serum has also been employed in erysipelas(2 )4), but no consistent 
results have been obtained. 
The experimental work of Lancefield and Todd(25)on the haem- 
olytic streptococci has shown that it is possible to prepare 
potent protective type -specific antibacterial sera. As the 
type features of any one strain however are at the most shared by 
a few other strains, it is obvious that practically every individual 
instance of streptococcal disease would call for a homologous 
serum, and such means therefore are scarcely practicable. 
Apart from serum, ultraviolet rays have also been applied 
in erysipelas. Even if this therapy were efficacious, which 
is doubtful, it is attended by numerous drawbacks: the necessarily 
long duration of the sittings where an extensive area of skin is 
involved is undesirable from the point of view of a really ill 
patient; and in head cases the dislike of most female patients to 
having their scalps shaved to permit the treatment is a serious 
obstacle. 
Local applications are of no direct value in limiting the 
spread or reducing; the swelling of the lesion but certain of them 
are of indirect value by the comfort which they give the patient. 
Indeed judicious expectant treatment and careful nursing are 
indispensable in severe cases and may determine the difference 
between recovery and death. 
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PRONTOSIL 
Chemistry and Physical Properties - Prontosil is the acid 
salt of 4 - sulphonamide - 2' -4'- diaminoazobenzol and its 
structural formula is represented thus:- 
S 02I'H N=N >NH2HC1 
NH2 
It is only sparingly soluble in water, dissolving in 
1600 parts slightly acid water and in 20,000 parts slightly 
alkaline water. It is therefore excreted very slowly, a 
large dose still colouring the urine weeks after adinistering.33) i í 
Men it is reduced it gives sulphanilamide and triaminobenzene. 
The latter compound is unstable and is almost certainly destroyed 
in the body. 
Prontosil soluble is a 2.% solution of the bisodium salt 
of 4' suiphonamidopheryl -2 -azo -7 acetylamino -1- hydroxy- 
naphthalene - 3, 6- disulphonic acid with the structural formula:- 
So r 22 
OH 
N=N NH . C o . CH3 
r:ao3s so3NA 
It is rapidly excreted practically all in the first few 
hours after a dose. 
Both the above drugs are red in colour and when administered 
to the human being in sufficient amounts impart a brilliant red 
colour to the urine, to the skin and various tissues in the body. 
Para- aminobenzene sulphonamide (or sulphanilamide) 
which, as will be shown, is now regarded as the active principle 
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of prontosil and the substance into which prontosil is converted 
in the body is u colourless compound and has the formula: - 
NH 
S02rH2 
"Prontosil" and "Prontosil soluble" are also known as 
"Red Prontosil" and sulphanila ide as "Prontosil album ". 
Pharmacological Action - 
Since Domagk's(1) original experiments in mice which were 
confirmed by Levaditi and `Taisman( 26) and by I;itti and Bovet( 
27) 
in which no attempt was made to explain the pharmacological action 
of these drugs, subsequent experiments have been carried out 
particularly in this country and in America which shed ruore 
light on their mode of action. 
In laboratory experiments undertaken at the Queen Charlotte's 
Hospital, Colebrook and Kenny(28) obtained very much the sPme 
results as had been noted by the previous investigators. In 
brief it was shown that not only could nice be protected to a 
marked extent by injection of prontosil solution prior to the 
administration of a lethal dose of haemolytic streptococci 
introduced into the peritoneal cavity, but they could be either 
cured or their lives considerably prolonged by giving the drug 
even some hours after infection. 
They further demonstrated in vitro a bacteriostatic effect 
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existing in the serum of patients being treated with prontosil. 
Buttle and his co- workers(29) in their animal experiments 
noted that p- aL1inobenzene sulphonamide had the same therapeutic 
activity as prontosil in streptococcal infections and that it was 
to be preferred since it was less toxic than prontosil and therefore 
permitted of larger dosage. 
It is to be observed that the above results could be 
achieved either by the parenteral or the oral administration of 
the drug. 
Some time later Colebrook, Thattle and O'ì. ara(30) having 
noted that Tréfoul(31) and his co- workers found p- aminobenzene 
sulphonamide to be as effective as prontosil in controlling 
streptococcal infection in the mouse proceeded to test the latter's 
hypothesis that sulphonamide was probably formed in vivo after 
the administration of prontosil. As a result of their further 
experiments they established two important facts:- (1) p- anino- 
benzene sulphonamide has a bacteriostatic and bactericidal action 
against small numbers of haemolytic streptococci in culture 
medium and in blood; prontosil itself on the other hand is inactive 
but on reduction an active substance is formed. (2) The blood 
of man or animals to whom sulphonamide or prontosil has been 
administered is bactericidal to haemolytic streptococci. Hence 
it is evident that the bactericidal action of the blood which 
follows the administration of prontosil in vivo is dependent on 
the reduction of the latter to p- sulphonamide. 
It was later shown by Long and Bliss(32) who confirmed the 
above findings that the normal rabbit cannot change prontosil 
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solution to the active substance and they suggested that for 
activation of prontosil, infection with haemolytic streptococci 
was necessary. 
Nearly all those investigators appear to have been struck 
by the discrepancy which exists between the limited bactericidal 
activity of prontosil and its derivatives, and their marked 
therapeutic activity in infected animals. Some(29) have 
believed that the enhanced bactericidal action of the blood was 
supplemented by that of the tissues of the animal as a whole, 
while others(3 °) have assumed an increased phagocytic activity 
of the leucocytes and monocytes. ì::ellon(33) and his co- workers 
however on the basis of their experiments have failed to detect 
these effects. 
r,t present it would seem most reasonable to conclude that 
whilst sulphonamide (and its parent substances prontosil and 
prontosil soluble) possess a bacteriostatic and bactericidal 
action against haemolytic streptococci, their actual mode of 
action in the body is unknown; that so far as can be judged 
"there are no qualitative changes in the character of the histologic 
response to the streptococcus haemolyticus "(33) as a result of 
their administration; but that the co- operation of the tissues 
of the host probably plays an important part in the curative 
action of the drugs. 
Absorption and Excretion - The human subject excretes sulphan- 
:ilamide partly unchanged and partly in conjugated form, viz., 
para- acetyl aminobenzene sulphonamide.(34) The latter has been 
found to be much less active than the sulphonamide itself(29). 
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Absorption from the gastrointestinal tract is complete or nearly 
complete in 4. hours. In administering a given amount of the 
drug in divided doses it takes from 2 - 3 days to establish 
equilibrium between the amount injected and the amount excreted; 
and after equilibrium is established it takes about the same time 
(2 - 3 days) to free the organism of the drug. 
Prontosil itself on account of its low solubility in water 
is excreted very slowly, a large dose still colouring the urine 
weeks after administering. When it is reduced it gives 
sulphanilamide and triaminobenzene. The latter compound is 
unstable and is almost certainly destroyed in the body. 
Prontosil soluble is rapidly excreted, practically all in 
the first few hours after the dose. Experimentally it is 
found that when sulphanilamide is injected (in mice) 75;-; of it 
is passed in 8 hours compared with one eighth of that derived from 
prontosil.(34) It has been estimated that under ordinary 
therapeutic dosage (2-.t gms per diem) a concentration of between 
1:5000 and 1:10,000 can be attained and maintained in the blood 
and presumably in the tissues.(35) In patients with impaired 
renal function the sulphonamide appears to be excreted more 
slowly. 
Toxicity - 
Whilst toxic effects with prontosil and sulphanilamide have 
been frequently described, the actual number of fatalities 
ascribed to them is few. How frequently in relation to the 
immense use which is made of these drugs such toxic effects occur 
is impossible at present to ascertain. On the one hand a 
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survey of the literature on the subject indicates that they may 
occur more frequently than one might suspect, at any rate when 
the drugs are administered without proper care and discrimination. 
On the other hand considerable series of prontosil -treated cases 
have been published where toxic manifestations are notably absent 
or negligible. It may be not out of place to suggest here 
that in so far as the innocuousness of a remedy may contribute to 
its haphazard exhibition, it is well in the interests of rational 
therapy that few potent remedies in the whole domain of medicine 
are without harmful potentialities. Provided however that such 
potentialities are borne in mind, that the signs of any toxic 
effects are promptly recognizable, and the effects themselves 
are capable of being promptly countered, it can scarcely be 
thought to detract from the value of a drug that the latter may 
be harmful. Bearing these points in view, and excluding the 
question of personal idiosyncrasy which there is no reason to 
think bulks more l arg.ely here than with any other drug, the 
following summary may be given of the possible toxic effects of 
prontosil: 
(1) li:ethhaemoglobinaemia and Sulphhaeimoglobinaemia. 
There is evidence that all drugs containing the group 
C6H5N (e.g. sulphanilamide) are capable of causing methhaemoglobin- 
aemia and facilitating the production of sulphhaeinoglobin.(36) 
The actual mechanism of the formation of methhaemoglobin in the 
blood is uncertain, but that of sulphhaemoglobin is known with 
a high degree of certainty. 
In brief the intracorpuscular sulphhaemoglobinaer.iia 
associated with the administration of the above drugs is due to 
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the combination of haemoglobin with hydrogen sulphide absorbed 
from the intestinal tract, this combination being a catalytic 
reaction in the presence of the drug. Normally any hydro en 
sulphide absorbed from the gut is rapidly destroyed in the blood, 
but if it be formed in excessive amounts, without the presence 
of a catalyst, or it it be formed in normal amounts with the 
presence of a catalyst, sulphhaemoglobin may be formed. The 
giving of magnesium sulphate concurrently with sulphanilamide is 
particularly prone to precipitate this reaction in virtue of the 
power of the former to liquify the bowel contents, and diminish 
absorption of fluid from the colon. Under these circumstances 
the more liquid content of the bowel enhances the growth of 
intestinal bacteria many of which split cystine, (one of the end 
products of protein digestion) to form hydrogen sulphide. It 
is hence easily conceivable that the conditions are now ripe, 
so to speak, for the formation of sulphhaemoglobin. 
Although the saline cathartics are outstanding in their 
faculty of producing the above effects, any purgative medicine 
apart from a purely mechanical one such as liquid paraffin will 
tend to act similarly; and furthermore magnesium sulphate or 
sodium sulphate applied as dressings for external wounds may 
produce identical effects. The practical deductions are 
obvious. Naturally too it would be unwise to give along with 
prontosil other drugs such as phenacetin and acetanilide containing 
the benzene ring, or sulphonal, or trional which themselves tend 
to produce ILlethhaemoglobinaemia. Sulphur- containing drugs too, 
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and excessive quantities of eggs in the diet should also be 
avoided on account of their tendency to promote the increased 
formation of hydrogen sulphide in the bowel. 
Fortunately methhaemoglobinaemia and sulphhaeriióglobinae:_:ia 
can be recognised with certainty by spectroscopic examination 
of diluted blood; and they may be frequently suspected in the 
presence of cyanosis of the lips and finger nails in patients 
receiving sulphanilamide. Since this cyanosis may not be 
obvious in anaemic patients, the blood should be deliberately 
and frequently examined by the spectroscope in patients whose 
haemoglobin is already low. The avoidance of excessive food 
residues in the bowel by giving a low- residue diet is also 
desirable in patients undergoing sulphanilamide treatment. A 
fatal case of sulphhaemoglobinaeuia has been reported by Frost.(37) 
This patient incidentally was receiving large doses of laxatives 
in addition to prontosil soluble and a related drug (benzyl- 
sulphanilamide) . 
The general experience however is that when the drugs are 
stopped methhaemoglobinaemia disappears within twenty -four hours 
and sulphhaemoglobinaemia steadily recedes though it may take 
some weeks to completely disappear. Oxygen is indicated in a 
severe case of methhaemoglobinaemia, and blood transfusion in a 
case where sulphhaemoglobinaemia endangers life.(38) Such 
radical measures are probably rarely necessary in practice. 
(2) Agranulocytosis. 
Since sulphanilamide possesses the benzene ring with an 
attached NH2 or amine group in common with such drugs as amidopyrine, 
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phenacetin, certain gold salts and arsphenarüine which may 
possibly in unknown circumstances cause an agranulocytosis, any 
possible effect in this direction should be borne in mind. One 
such case of agranulocytosis in a patient undergoing sulphanilamide 
treatment has been described by C. J. Young.(39) It may or 
may not have been due to the giving of the drug. 
Uodel(40) has likewise described the same condition in a 
patient receiving treatment by a similar drug (benzylsulphanilamide). 
Both cases, as might be expected, were fatal. 
Since writing the above paragraph I have myself observed a 
case of complete agranulocytosis following sulphanilamide treatment 
in a patient suffering from puerperal septicaemia. Repeated 
blood transfusions were without avail to this patient. 
Histological examination of the bone marrow at autopsy showed a 
complete absence of the granular white elements. 
(3) Drug Rashes. 
The occurrence of a drug rash accompanied by fever following 
sulphanilamide treatment has been reported by Hageman and BlakeÇ43) 
In 21 out of 134 consecutive cases observed by these workers 
fever of varying degree appeared usually between the 7th and 
10th day of the therapy accompanied in many by a morbilliform 
rash. 
Because of the time incidence of the symptoms and of the 
fact that they frequently appeared after the drug had been 
diminished in dosage or even discontinued altogether, they 
attributed the symptoms to an antigenic action on the part of 
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the drug rather than to its actual concentration in the tissues. 
So far as they Imow, no permanent injury to the body resulted from 
the rash. 
Similar symptoms to the above were also reported by 
Eassell(11h) in L4. out of a series of 14 patients. 
( '4.; Other toxic effects 
The development of acute haemolytic anaemia in a patient 
during the administration of sulphanilamide has been described. 
(41 ) 
With this single exception other toxic effects as a result of 
sulphanilamide are apparently slight and scarcely sufficient to 
warrant the cessation of the administration of the drug. Thus 
a mild irritant eff-ct on the urinary tract has been described.28'42) 
No case of permanent renal damage has been recorded. 
Such symptoms as headache or "stuffiness" in the head, 
nausea and vomiting, pyrexia, and difficulty of micturition have 
occurred occasionally in patients receiving prontosil. Obviously 
such symptoms may occur in any patient who is ill under any form 
of treatment. 
THE VALUE OF SULPHANILAi.:IDE IN ERYSIPELAS. 
Presentation of original data - 
The present section refers to the treatment of seventy - 
seven consecutive cases of erysipelas treated by prontosil or 
sulphanilamide durin the twelve -month 17th June 1936 - 
17th June 1937. 
Method of administration and Dosage. 
For the first five months the original "red" prontosil of 
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Messrs Bayer Products Ltd., was employed. Thirty -four patients 
were thus treated. Of these, 30 received prontosil orally and 
a 2.5) solution of "prontosil soluble" intramuscularly, three 
received oral medication only, and one intramuscular medication 
only. 
During the next seven months sulphanilamide by mouth was 
substituted for prontosil. Of the forty -three patients 
treated during this period, thirty -four received sulphanilamide 
orally + prontosil soluble intramuscularly. The remaining 
nine received only oral addinistration of sulphanilamide. 
The above data may be summarised thus: - 
Prontosil Tablets only 3 
Prontosil Tablets + prontosil soluble 30 
Prontosil soluble only 1 
31+ 
Sulphanilamide only 9 
Sulphanilamide + prontosil soluble 34 
143 
Total 77 
Dosage: - The treatment commenced on admission to hospital, 
0.6 - 0.9 gms being given thrice daily by mouth and 5 - 10 ces 
of the solution 8 or 12 hourly by intramuscular injection. In 
the great ..iajority of cases the dosage was 1.8 kris orally of 
prontosil or sulphanilamide and 30 ccs of the 2.5% solution of 
prontosil soluble intramuscularly in the 24 hours. When 
pyrexia subsided which it normally does under the above regime 
within 48 hours, the injections were stopped and the oral 
medication continued for 10 days subsequently. This was 
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thought desirable because of the notorious tendency of erysipelas 
to recur and though the duration of oral treatment was purely 
empirical, not a single case of recurrence was observed in the 
whole series. hence the procedure was considered satisfactory, 
and there was no obvious reason to change it. The average 
total case dosage was thus 60 ccs of 2.5 prontosil soluble and 
25.2 gins of prontosil or sulphanilamide. 
Toxic Effects - No case of methhaemoglobinaemia or sulphhaemo- 
:globinaemia was observed, although during the last six months, 
at any rate, cyanosis was scrupulously searched for and the blood 
submitted for spectroscopic examination where the slightest 
suspicion of its presence existed. In addition, samples of 
blood were taken at random every now and then to exclude the 
presence of these complications where they might not be suspected. 
It may be stated here that drastic purgatives are rarely given in 
the practice of this hospital, mild laxatives and simple enemas 
bein`; preferred. On the other hand magnesium sulphate solution 
as a local application is frequently applied in erysipelas. 
Where the skin is unbroken it would seem that absorption of this 
salt through the skin is unlikely. 
One case of difficulty in micturition was noted during the 
administration of the drug. It is impossible to say whether 
there was any causal connection between the two. 
One patient complained of nausea which seemed to be related 
to the taking of the drug and one of a "cold in the head ", the 
signs of which could not be detected. 
On the whole therefore the statment appears to be justified 
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that in the present series under consideration, serious toxic 
manifestations due to the administration of the drug were wholly 
absent, and slight ones doubtfully or rarely present. 
THE RESULTS OF TREATMENT AND THE ACTION OF PROIt T OS IL IId ERYSIPELAS. 
THE RASH - In the first twenty -four hours following administration 
of the drug an advance of the process was observed in eighteen 
cases, which was usually limited to one side of the eruption. 
Simultaneously, however, the edges at other parts of the 
inflammatory area were less marked, and the oedema usually 
appreciably less. 
In the remaining 59 cases even on the first day of treatment 
the spread of the eruption was arrested and healing began at 
once. 
During the second twenty -four hours the improvement was 
quite remarkable. Advance of the lesion at this stage was 
only observed in twelve out of the seventy- seven cases, and 
except in three of the twelve the spread was slight, that is to 
say, not more than about an inch in extent. The three exceptions 
will be described in greater detail later. In other words 
during the second twenty -four hours from the instigation of 
the treatment, sixty -five of the seventy -seven cases showed no 
evidence of continued activity of the erysipeloid process whether 
in the form of increased swellin.- or increased extension. In 
eight of the sixty -five it remained unaltered and began to subside 
the following day, that is during the third twenty -four hours. 
In the other fifty -eight, even during the first twenty -four hours 
in many, but more especially during the second twenty -four hours, 
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the brilliant red was observed to fade to a dull glow, the 
blisters when present collapsed, the tension was eased, and the 
pain and tenderness receded. 
The paling and the subsidence of the swelling begin mainly 
at the periphery, whilst the parts originally implicated remain 
at first unaltered. Soon, however, the whole process subsides 
and by the fifth or sixth day healing has taken place in all, 
the only signs to be observed then being merely a brownish staining 
of the skin or a little yellowish crusting. A few cases were 
noticed where the angry efflorescence fell into red islets 
separated by pale strips. In the facial cases the oedema of 
the eyelids and the redness of the ears and nose improved perhaps 
least. 
Suzmaing up the above findings on the behaviour of the 
erysipelas rash under sulphanilamide, it is clear that the effect 
of the drug is in the great majority of cases manifest quickly, 
that the turning -point in the disease is generally about the 
end of the first 24 hours, and that during the second 24 hours 
in all but a small minority the rash steadily recedes. 
These effects may also be tabulated thus: - 












































Effect on Toxaemia 
Although in the course of an infectious disease well -known 
indications of toxaemia exist such as nervous prostration and 
delirium, a dry furred tongue, anorexia and nausea, disordered 
heart action and feeling of misery, the composite picture of the 
toxic state is often difficult to define and remains fundamentally 
a matter of clinical judgment. i:.oreover the presence of under- 
lying constitutional disease and defect or co- incident complication, 
of senility at one end of life, and malnutrition and feebleness 
frequently at the other tend to obscure the issue and to introduce 
factors at times of greater moment in relation to the well -being 
of the patient than the fever itself. Hence accuracy in this 
regard can only be approximate. Nevertheless an attempt has 
been made in each case to as ,,ess the degree of toxaemia, and in 
doing so the individual patient's subjective feelings of malaise 
or otherwise have been carefully taken into consideration. 
An examination of the case records points to the conclusion 
that 31 of the patients in this series were seriously ill and the 
toxaemia considerable. The remaining 36 cases were regarded 
as mild. In coming to this assessment an endeavour has been 
.wade to guage the severity of the erysipelas as such apart from 
the influence of any intercurrent conditions which were already 
present. Thus a mild attack in a feeble individual is classified 
as mild though it may well have carried a graver prognosis than 
a severe attack in a robust individual. 
It can be definitely stated at once that without exception 
abatement of toxaemia ensued rapidly following the exhibition of 
prontosil. Allowing for human fallacies on both sides, a review 
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of this series convinces one that so far as the alleviation of 
pain and distress and the subjective feeling of relief are 
concerned, prontosil acts like a charm in erysipelas. Lany 
patients who had had a previous attack of the disease and were 
dreading the present one remarked on how lightly they had got off 
this time. So much is this the case and so evident the 
improvement in the patient's general condition, that one seldom 
has had cause for anxiety in a patient undergoing the treatment. 
Indeed the response to prontosil in erysipelas may be looked for 
as confidently as that to a dose of antitoxin in an early case 
of diphtheria. 
THE TE; PERATURE 
The effect on the temperature is equally striking. Ten 
of the 77 patients in the series had no pyrexia on admission. to 
hospital. In the 67 patients who had pyrexia the average 
duration of the latter following the exhibition of prontosil 
(or sulphanilamide) was 1.8 days. It is usual for the temperature 
to fall by crisis during the second 12 hours to a subfebrile level. 
During the first 12 hours the temperature may either remain 
stationary, rise, or commence at once to fall. During the 
second 24 hours it may remain subfebrile or normal. On the 
third day it is normal and remains so. In certain cases there 
is a steady fall in temperature during the first 12 Or 24 hours, 
succeeded by a rise, though not to the original level, in the next 
12 hours. This is followed at once by defervescence. 
In only thirteen of the cases was the temperature still 
elevated on the third day following treatment, and in only four on 
the fourth day. Of the latter in two it lasted 5 days, one of 
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these, the only fatal case, being a man of 72 in the terminal 
stages of malignant caehexia, whose erysipelas had already entirely 
subsided fully two days before death. Of the remaining two 
cases whose primary pyrexia exceeded 3 days, the duration of the 
latter was seven days in one, and eighteen days in the other. 
These results are tabulated in Table II, and a few 
illustrations of the different temperature curves are shown. 
Although these types of temperature following prontosil are very 
characteristic and easily recognised, it has not been possible to 
correlate them with any particular factor, such as age, severity 
of attack, time of initiation of treatment, or situation of the 
lesion, etc. 
Table II. Illustrating the behaviour of the Temperature 
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Examples of these are shown below: - 
A. Immediate Fall of Temperature by crisis (2L. cases) 
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B. Temperature stationary during 1st 12 hours. Fall by 
crisis during 2nd 12 hours (6 cases) 
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C. Temperature rises during 1st 12 hours followed by fall 
by crisis (18 cases) 
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D. Initial fall during 1st 12 hours - followed by rise, then 
final crisis (15 cases) 
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Of the four patients whose pyrexia exceeded four days one 
was the man of 72 with advanced carcinoma who died after subsidence 
of the erysipelas. 
C R S 4 47S 
Cn 
His temperature chart is repmnduced. 
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The second was a baby of 3 months whose erysipelas 
originated from a vaccination pock on the leg and who developed 
erysipelas migrans. This baby was exceeding ill at the start 
of the treatment and it was felt that although the erysipelas 
wandered all over the body the toxaemia was remarkably slight. 
His temperature chart is shown below. 
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The third was a baby of fourteen months also with 
erysipelas of the leg originating 
been opened prior to admission. 
to his thigh. His temperature 








from an abscess which had 
The rash spread upwards 
chart was as follows: 
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The fourth was a baby of five months with erysipelas of 
the thigh which went on to suppuration. Her temperature 
chart is reproduced below. 
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It may be observed in this chart that the temperature curve 
at first appears to fall into Group D, but that defervescence is 
delayed by the occurrence of abscess -formation. 
It is interesting and perhaps significant that of those 
four "failures ", one was an old man whose pyrexia and death were 
almost certainly unconnected with his erysipelas. 
The remaining three were young babies in one of whom the 
erysipelas ori;;inated from a surgical wound, and in another from 
a vaccination lesion. In the third suppuration developed. 
In the whole series of seventy -seven cases as sho n later only two 
other cases were complicated by suppuration. It would be 
-108- 
foolish to draw definite conclusions from small numbers, but all 
the sale there is at least a presumption that in the case of infants 
some factor is perhaps lacking in the response to sulphanilamide 
which is present in the case of older individuals. 
The last four charts shown_ are quite unique in the series 
under review both as regards the duration and the character of 
the pyrexia. Those illustrating the types A, L, C, and D 
(comprising the 63 remaining cases who had pyrexia on admission 
to hospital) are on the other hand typical. It is readily 
admitted that similar temperature curves to those could be found 
in any considerable series of cases, but never with such unvarying 
constancy. 
FOLLOWING PRONTOSIL THERAPY. 
Suppuration: There were three instances of suppuration in the 
series:- The first was the baby J. referred to above who 
had been ill for 8 days prior to admission to hospital. Her 
erysipelas involved the buttocks, external genital organs, and 
the lumbar region. She developed abscesses in the thigh and 
labium majus and as shown in the chart her temperature subsided 
shortly after the abscesses were opened. 
The second was a man of forty whose erysipelas originated in 
a chronic leg ulcer. His eruption subsided quickly, though 
the leg remained markedly oedematous due apparently to a 
periphlebitis and lymphatic obstruction. An abscess developed 
in the calf of the leg about a fortnight later. 
The third and remaining case which developed suppuration was 
-109- 
a woman of 53 who had had her breast amputated for carcinoma a 
fortni, ;ht previously. The left upper extremity was brawny and 
swollen - a case of "phlegí.ionous erysipelas" possibly combined 
with some lymphatic obstruction, and abscesses over the elbow 
were opened on the day following admission to hospital. She 
developed two further abscesses later, one over the right radius 
and one deep to the occipital muscles. Her subsequent progress 
was uneventful. 
Pseudo -uraemia - This occurred in a female patient aged 39 who 
had a moderate attack of facial erysipelas. She was actually 
convalescent and was getting up daily preparatory to going home 
when she had a uraemic convulsion. 
She was considered a case of essential hypertension with 
secondary renal changes and showed a blood pressure of 
240rmq/110mm, papilloedema, a blood -urea of 193 mgm % and 
albuminuria. She made an excellent recovery subsequently. 
This complication could scarcely be connected with her 
erysipelas directly. 
Thus in the whole series of seventy-seven prontosil treated 
cases only three complications occurred directly attributable to 
the erysipelas, viz., suppuration in three cases, and in one of 
these pus formation had almost certainly taken place before 
treatment was instituted. 
INCIDENCE OF RELAPSE - In the entire series not a single instance 
of relapse was observed. 
MORTALITY - One patient died - a man of 72 referred to above. 
-11 0- 
There is no reason to think that his erysipelas had any bearing 
on his death at all. The case mortality in the series was 
thus 1.3; and that attributable to the erysipelas I;il. 
A COMPARISON OF THE PRONTOSIL- TREATED SERIES WITH THE 
CONTROL SERIES. 
The 462 cases of erysipelas admitted to the City Hospital 
Aberdeen in chronoloLical antecedence to the prontosil series have 
been taken as a control group. In order to facilitate comparison, 
and at the same time show what fluctuation there may be, if any, 
from year to year in the various factors which might be expected 
to influence the course and prognosis of the disease, the series 
is divided into six groups of seventy -seven which are compared 
first separately and then as a whole with the prontosil group. 
The cases date back to January 1923. 
The general treatment of the control series and the prontosil 
series has probably been fairly uniform. The same ward has 
been used for the reception of the cases during the whole period, 
and for the past seven years at any rate the same sister has been 
in charge of the ward. So far as can be ascertained by 
examination of the case charts and by personal incuiry, no 
particular difference has been :wade in the general medical 
attention given the erysipelas patients during the whole period 
under review. 
In attempting the comparison, only those points are taken 
into consideration on which no doubt can exist. For example 
no attempt is made to compare the toxaemia in the control cases 
with that in the prontosil cases. So far as the case -recording 
is concerned, the control series probably benefits from the 
comparison: for instance in ascertaining the incidence of spread 
-112- 
of the eruption in the latter no assumption has been made of 
its spreading unless specifically mentioned in the case records. 
There is reason to think that in certain cases spread has taken 
place though mention of it is omitted from the actual notes on 
the case. Hence where the balance is weighted at all, it is 
probably in favour of the control series. 
The following table gives a summary of the special treatment 
accorded to the control cases. 
Table III. Special Treatment accorded to the Control Cases. 
Antistreptococcal serum only. 
Antistreptococcal Serum + U.V.R. 
U.V.R. only 
Streptococcal vaccine 
Antistreptococcal Serum + Streptococcal Vaccine 








The serum used was erysipelas antitoxin in the great majority, 
occasionally scarlatinal antitoxin. 
The cases receiving symptomatic treatment only appeared 
to be milder on the whole than those receiving serum. 
-113- 
In the following tables (IV - XI) comparative statistics 
are presented on:- 
(1) Average Duration of Illness before admission to Hospital 
(Table IV) 
(2) Average Total Duration of Primary Pyrexia (Table V.) 
(3) Average Duration of Primary Pyrexia following treatment 
(Table VI.) 
(4) Average Duration of Stay in Hospital (Table VII) 
(5) Incidence of spread of eruption noted after 24 hours 
following institution of Treatment (Table VIII) 
(6) Incidence of Relapse (Table IX) 
(7) Incidence of Complications (Table X) 





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































An exaiination of the Tables V - XI enables one enables one 
to present the following conclusions: - 
The average total duration of the primary pyrexia is 
considerably curtailed in the prontosil- treated cases, viz., 
4.4 days as compared with 7.9 days; and since the duration of the 
pyrexia prior to hospitalization was virtually the same in the 
control series as in the prontosil series, other things being 
equal, this curtailment of pyrexia would appear to be due to 
the administration of prontosil. The average duration of 
pyrexia following admission to hospital was 1.6 days compared 
with an average of 4.9 days in the control cases. 
The incidence of extension of the skin lesion in the 
prontosil- treated cases in the second 24 hours following admission 
to hospital is almost a quarter of that in the control series, 
the proportion showing spread at this stage in the 6 control 
groups varying from 57% - 75% with an average of 61% and that 
in the prontosil group being 16. 
The incidence of complications in the six control groups 
varies from 18.3% - 26% with an average of 22.7 ;>, whilst in the 
prontosil group it amounts to 5.2% or less than a quarter of that 
in the control series. 
The average length of stay in hospital in the prontosil 
series was 20 days - in the control series 232 days. This 
difference is not significant. It ìiust be pointed out here 
however that in the prontosil group many of the patients were 
kept in hospital much longer than was strictly necessary. In 
other words in the practice of this hospital an endeavour is made, 
-119- 
whenever the accommodation is available, to ensure a leisurely 
convalescence in hospital particularly for women with families 
living in poor circumstances, because it is known that in the 
majority of cases these women do not get a holiday on discharge 
from hospital but are inLaediately plunged into their daily housework. 
It is, as a matter of fact, obvious from the case charts in 
the earlier control cases particularly in the years 1928, 1929, 
1930, 1931, and 1932 that the patients were discharged much 
earlier from hospital without any convalescent period intervening 
than has been the custom in the later cases. 1933, 1934, and 
1935 were epidemic years, and it was not often possible then, since 
the hospital was full, to keep patients for any convalescent 
period. Although therefore it is impossible to show it 
categorically, it is almost certain that had the object been in 
view, it would have been easy to demonstrate a shortening of the 
period of hospitalization in the prontosil- treated cases, by 
cutting down the convalescent period in hospital. 
The incidence of relapse in the six control groups varies 
from 10.4% - 13% with an average for the whole series of 11.2. 
Not a single case of relapse occurred in the prontosil -treated 
series. 
The case- mortality in the six control groups varied from 
6.5% - 16.9% with an average of 11.7. Only 1 death occurred 
in the prontosil -treated group (giving a fatality rate of 1.3;x) 
and as already mentioned the erysipelas had probably nothing to 
do with death in this case. 
In order to discover whether any particular factors were 
-120 - 
absent in the prontosil group as compared with the control 
group, which may have acted adversely in a patient suffering 
from erysipelas, the following points were investigated: 
(a) the age of the patient, erysipelas being particularly serious 
at the extremes of life; (b) the sex of the patient, since the 
pro¿,riiosis in females is usually considered better than in males; 
(c) the presence of intercurrent disease or associated complications 
since these also may load the scales against a patient; and 
finally (d) the anatomical situation of the lesion. 
Those points are illustrated in the following Tables XII, 
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































INCIDENCE OF INTERCURRENT DISEhSE OR COLIPLICkTION 
Under this heading two points are considered: - 
(a) The presence of underlying constitutional disease or 
disability or of intercurrent infection not directly 
associated with the erysipelas. 
(b) The presence of complications associated with the 
erysipelas and already present on ad:Assion to hospital. 
Here the complications mentioned are either those which 
apparently 1-,recipitated the erysipelas, or on the other 
hand they are, e.g. albuminuria, due to the erysipelas. 
It is obvious that an incrased incidence of either the 
one or the other viz., (a) or (b) might adversely influence the 
prognosis - the first sugzesting a possible reduction in the 
patient's ability to withstand the acute infection, and the 
second a severe attack, poor resistance or possibly an 
additional handicap. 
-124- 
Table XIV. Incidence of Complicating Factors already 
present and independent of the Erysipelas. 










Charcot s Disease 
Hydrocephalus 
Longo l i si:i 















1 (463 - 539) 
1 B. Coli Pyuria 




1 5th 77 (309-335) 
1 Chronic Nephritis 1 
1 Arteriosclerotic 
1 Kidney -Hypertension 1 
1 Lyocarditis- Senility 1 
Osteoporosis 1 
epatic Cirrhosis 1 Osteoarthritis 











3rd 77 (155 -231) 
tHaemateuesis 
















6th 77 (386 -462) 
Faucial Diphtheria 1 
Laryngeal Diphtheria 1 
Rheumatoid Arthritis 1 
:yocarditis 1 
Hypertension 1 
Aortic Aneurysm 1 
Senility 2 
Eitral Stenosis 1 
Otitis Media 1 
I.:yxoederna 1 






















Table XV. Incidence of Complications present on admission 
and associated with the Erysipelas. 
1st 77 (1 - 77) 
±Alburninuri a 
Acute Otitis Ledia 










2nd 77 (78-154) 
Albuminuria 








rd 77 (155-231) 
Albulai nur i a 1 
Ph iinos i s 1 
Streptococcal Tonsilitis 2 
Acute Otitis Media 2 
Mastoiditis 3 
Cervical Adenitis 1 
#Burns 1 
+Where equivalent to 
1 Esbach; where only 
a trace is present 
it is disregarded. 
X Developed üaematemesis 
4th 77 (232 -308) 
Albuminuria 










6th 77 (386 -462) 
Suppuration 4 
Albuminuria 3 
Acute Nephritis 2 
Streptococcal Tonsilitis 1 
Lobar Pneumonia 1 
Varicose Ulcer 2 
Prontosil Group 




















From a survey of Tables XIV and XV therefore there is 
no indication whatever of a lower incidence of complicating 
factors associated with the erysipelas or of debilitating 


















































































































































































































































































































































































































































































































































































The following table illustrates the actual incidence of 
complications following admission to hospital. It serves to 
show the common run of complications which are apt to occur in 
erysipelas and the remarkable dearth of such complications in 
cases treated by prontosil. 
Table XVII. Actual Complications developing in the Control 
and in the Prontosil Cases. 




























































L.th 77 (232-308) 
3 Suppuration 7 
2 Suppurating Adenitis 1 
1 Adenitis 1 
1 buminuria 



















5th 77 (309 -335) 
Suppuration 6 
Cervical Adenitis 1 
Suppurating 



















6th 77 (386 -462) 
Suppuration 5 
Albuminuria 2 
Acute Nephritis 2 
Glossitis 1 













(Pseudo -uraemia 1 
Total 4 
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It is perhaps particularly noteworthy that whereas in 
the control groups such complications as albuminuria, nephritis, 
pneumonia and bronchitis, septicaemia and pyaemia occur with 
considerable frequency, not one of those complications developed 
in the prontosil series. 
One is thus forced to the conclusion in view of the 
constancy of the factors involved in influencing the prognosis 
of erysipelas, either that prontosil has had a markedly 
beneficial action in this disease far superior to that of serum 
if any, or that the type of erysipelas which was fairly uniform 
from January, 1928 - June 1936, suddenly became of a milder 
character at the time when prontosil therapy was instituted. 
It is frankly impossible to find any direct or indirect evidence 
of the latter alternative. All the available evidence 
suggests that there has been no significant change in the type 
of erysipelas prevailing from June 1936 - June 1937. 
-129- 
DISCUSSION. 
The success of prontosil in relation to the prevention 
and treatment of haemolytic streptococcal infection in 
experimental animals, first announced in this country by 
Professor Horlein(45) in October 1935 and subsequently confirmed 
by numerous workers has never been seriously questioned. 
Never before had a drug when given by mouth exhibited a regular and 
specific bactericidal effect. Whilst its exact mode of action 
in the tissues remains uncertain, it is now well established that 
it is not effective until it is broken down to sulphonamide. 
The latter has a direct bactericidal action on the haemolytic 
streptococcus even in such low concentration as 1:18000(29) and 
it would appear, ipso facto, that this bactericidal property is 
at least an important element in its therapeutic activity. 
Previous attempts to render the blood bactericidal have usually 
been handicapped by the fact that any agent introduced into the 
blood -stream in sufficient concentration to kill bacteria has had 
a poisonous effect on the tissues themselves. hence it has not 
been feasible to employ in an effective degree known bactericidal 
agents such as acriflavin, mercurochrome etc., in an attempt to 
sterilize the blood without running a serious risk of killing the 
patient along with the infecting organism. certain of the 
organic arsenical compounds e.g. sulpharsenal, novarsenobillon 
have been employed (notably by Colebrook) with possibly a certain 
degree of success in combating haemolytic streptococcal infections, 
but here again the known leucocidal effect of these compounds not 
to mention their poisonous action on the liver, kidneys and nervous 
tissues, has placed them outside the bounds of safe therapy. 
-13o- 
In the case of prontosil on the other hand we have a drug which 
is effective when given orally; is bactericidal in low 
concentration in the form of sulphonamide to which it is broken 
down in vivo; is not usually leucocidal; and is not in the 
dosage commonly employed poisonous to the liver, kidneys or nervous 
system. 
Whilst the use of sulphonamide in human infection is still 
on trial, evidence is steadily accumulating that the promise 
borne of the experimental work is being amply fulfilled in 
clinical practice. The fact alone that several well authenticated 
cases of recovery from haemolytic streptococcal meningitis, a 
disease which invariably carries a well -nigh hopeless prognosis, 
following sulphonamide therapy have been recorded, is telling 
evidence on behalf of the value of the drug. The results 
obtained in the cases of erysipelas described in the present 
thesis are on a less dramatic scale, but nevertheless their 
comparison with those in the control series makes it difficult to 
avoid the conclusion that it is prontosil (or sulphonamide) only 
or mainly which has determined the more favourable outcome in 
the cases where it was employed: The lowered mortality; the 
curtailment of pyrexia, toxaemia and extension of the lesion; 
the lessening of complications; and the elimination of relapse. 
The last- mentioned of these suggests to one that although the 
bactericidal action of the drug is probably of paramount 
importance, an increased resistance on the part of the tissues, 
or the assertion of an immunity hitherto lacking in this disease, 
may also be brought into play. 
So far the optimum dosage of the drug has not been 
-131- 
established. In the present series of cases those patients 
who received oral medication only appeared to do as well as those 
who had the drug also parenterally. In view of what is known 
of its absorption from the alimentary tract a four -hourly interval 
between doses would probably be the most desirable. Possibly 
one or two injections at the outset might expedite the action 
of the drug in urgent cases. The following chart in an 
octogenarian with erysipelas who was treated at home may be of 
some interest in this respect. She had a severe attack of 
erysipelas in the leg and thigh, and as she was old and feeble 
with a senile myocardium the prospects were not good. She 
was given sulphonamide orally for two days, but the rash 
continued to spread and her general condition deteriorated. 
An injection of prontosil soluble was then given and improvement 
followed at once. Both oral and parenteral medication were 
stopped on defervescence and fading of the rash. A relapse 
occurred ten days later and was again immediately controlled 
by a single injection after apparently hanging fire under oral 
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This chart also indicates that the giving of the drug for 
some days after defervescence has set in is desirable to prevent 
relapse. A few injections intramuscularly by for-ling a depot 
from which absorption may take place over a more prolonged period 
may attain the same object. 
So far as the series of cases described is concerned 
contraindications to the e.:iployLient of sulphonamide have not been 
found. The drug was well borne by young and old alike, and 
by the subjects of chronic cardiac, renal, and nervous disease. 
Toxic effects if they were present were negligible and idiosyncrasy 
did not occur. 
Undoubted cases of sulphhaemoglobinaemia and of agranulocytosis 
due to the drugs have however occurred in the hands of various 
-133- 
observers and are a salutary warning that though usually well 
tolerated sulphonamide may occasionally have serious and even 
fatal effects. 
SUMMARY AND CONCLUSIONS. 
1. A series of seventy -seven cases of erysipelas treated 
by the sulphanilamide drugs is presented. 
2. An analysis of the cases in relation to the behaviour of 
the rash, the toxaemia, and the pyrexia, the incidence of 
complications and of relapse, and the fatality rate, 
indicates that the results obtained are significantly superior 
to those derived from symptomatic or serum treatment. 
3. So consistent are the results prevailing that 
sulphanilamide may be regarded as specific in erysipelas. 
4. Although certain toxic effects are known due to the 
administration of sulphmsriide, the latter is to be regarded 
on the whole as a safe and not unpleasant means of treatment. 
5. It may be that in infants the response is not so good 
as in older individuals, but the numbers in this series are 
too few to be decisive on this point. 
6. The exact mode of action of sulphonamide in the body 
is unknown. In the light of experimental knowledge and 
clinical observation however, a directly bactericidal action 
in the tissues is probably supplemented by an increased 
activity of the normal defence forces. 
I oui indebted to Dr. John Smith, Bacteriologist to the 
City and County of Aberdeen for the bacteriological findings 
reported in Part I of the above thesis. 
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